| NCT01972490 | Xu jianmin | Colorectal Neoplasms | 2013-10 | PHASE4 |
| NCT00271505 | M.D. Anderson Cancer Center|Genentech, Inc. | Non-Small Cell Lung Cancer | 2005-12-05 | PHASE2 |
| NCT05318443 | Shanghai Institute Of Biological Products|Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Non-squamous Non-small-cell Lung Cancer | 2020-04-17 | PHASE3 |
| NCT00464347 | National Eye Institute (NEI)|QLT Inc. | Age-Related Macular Degeneration | 2007-01 | PHASE2 |
| NCT01439178 | Seoul St. Mary´s Hospital | Complications of Diabetes Mellitus | 2011-08 | NA |
| NCT01331616 | West Penn Allegheny Health System | Glioblastoma|Optic Neuropathy | 2011-03 | EARLY_PHASE1 |
| NCT00113230 | M.D. Anderson Cancer Center|Genentech, Inc. | Rectal Cancer | 2005-02 | PHASE2 |
| NCT00545792 | Dana-Farber Cancer Institute|Genentech, Inc.|Brigham and Women´s Hospital|Beth Israel Deaconess Medical Center|Massachusetts General Hospital|Lowell General Hospital|Saint Anne´s Hospital | Cervical Cancer|Endometrial Cancer|Ovarian Cancer|Vaginal Cancer|Carcinoma of the Vulva | 2007-05 | PHASE2 |
| NCT02090322 | Universidad Autonoma de San Luis Potosí | Retinopathy of Prematurity | 2013-09 | NA |
| NCT00081861 | M.D. Anderson Cancer Center|Genentech, Inc. | Lymphoma | 2004-03 | PHASE2 |
| NCT00462423 | Lynn E. Spitler, MD|Celgene Corporation|Genentech, Inc. | Metastatic Malignant Melanoma | 2007-04 | PHASE2 |
| NCT00416637 | Herbert Hurwitz, MD|National Cancer Institute (NCI) | Unspecified Adult Solid Tumor, Protocol Specific | 2004-01 | PHASE1 |
| NCT00555594 | Asociación para Evitar la Ceguera en México|National Council of Science and Technology, Mexico|Universidad Nacional Autonoma de Mexico | Corneal Neovascularization | 2006-09 | PHASE2|PHASE3 |
| NCT01083966 | Northwell Health|Feinstein Institute for Medical Research|Hofstra North Shore | Vestibular Schwannoma | 2011-08 | PHASE1 |
| NCT01760746 | University of British Columbia | Proliferative Diabetic Retinopathy (PDR) | 2012-07 | |
| NCT00559936 | Massachusetts Eye and Ear Infirmary | Corneal Neovascularization | 2007-02 | PHASE1 |
| NCT01787669 | University of Sydney|Allergan | Diabetes|Diabetic Macular Oedema|Diabetic Macular Edema|Diabetic Retinopathy | 2013-06 | PHASE2 |
| NCT01202890 | New Mexico Cancer Research Alliance|Celgene Corporation | Ovarian Cancer|Epithelial Ovarian Cancer|Fallopian Tube Carcinoma|Primary Peritoneal Carcinoma | 2010-09 | PHASE1 |
| NCT01183494 | University of Chicago|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | Metastatic Colorectal Cancer | 2009-12-12 | PHASE1 |
| NCT00047762 | Genentech, Inc. | Colorectal Cancer | 2002-10 | PHASE1 |
| NCT04633564 | Mylan Pharmaceuticals Inc | NSCLC Stage IV | 2017-01-21 | PHASE3 |
| NCT01085734 | Maturi, Raj K., M.D., P.C. | Retinal Vein Occlusions | 2010-03 | PHASE4 |
| NCT02272413 | Boehringer Ingelheim | Carcinoma, Non-Small-Cell Lung | 2015-07-08 | PHASE3 |
| NCT03676192 | Celltrion | Adenocarcinoma of Lung | 2019-02-01 | PHASE3 |
| NCT00109057 | Genentech, Inc. | Cancer | 1998-02 | PHASE2 |
| NCT00511992 | University of Oklahoma|Genentech, Inc. | Advanced Ovarian Carcinoma|Primary Peritoneal Carcinoma|Ovarian Carcinosarcoma | 2007-07 | PHASE2 |
| NCT00605722 | Hoffmann-La Roche | Liver Cancer | 2008-03 | PHASE2 |
| NCT01022918 | Centre Georges Francois Leclerc|National Cancer Institute, France|Association de Neuro-Oncologues d´Expression Francaise|UNICANCER|Hoffmann-La Roche|Pfizer | Naive Unresectable Glioblastoma | 2009-01 | PHASE2 |
| NCT01330524 | Shahid Beheshti University of Medical Sciences | Acute Nonarteritic Anterior Ischemic Optic Neuropathy | 2010-01 | PHASE1|PHASE2 |
| NCT00114946 | Genentech, Inc. | Colorectal Cancer | 2005-05 | PHASE4 |
| NCT00308607 | University of Turku | Metastatic Melanoma | 2005-08 | PHASE2 |
| NCT03030430 | Bio-Thera Solutions | NSCLC | 2016-03-15 | PHASE1 |
| NCT01526837 | Brain & Spine Surgeons of New York | Glioblastoma Multiforme | 2011-10 | PHASE1 |
| NCT00667277 | Ronald Hoffman|Myeloproliferative Disorders-Research Consortium|National Cancer Institute (NCI) | Myelofibrosis | 2008-03 | PHASE2 |
| NCT03247673 | Celltrion | Healthy | 2017-08-07 | PHASE1 |
| NCT05446870 | Merck Sharp & Dohme LLC | High-grade Serous Ovarian Carcinoma|Ovarian Carcinoma | 2022-07-25 | PHASE2 |
| NCT00531336 | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | Macular Degeneration | 2006-07 | PHASE2 |
| NCT00735306 | Duke University|Genentech, Inc. | Pancreatic Cancer | 2008-07 | PHASE1 |
| NCT00723125 | William Sikov MD|Yale University | Breast Cancer | 2008-09 | PHASE2 |
| NCT00096967 | Genentech, Inc. | Breast Cancer|Colorectal Cancer|Metastases | 2002-10 | PHASE3 |
| NCT00597402 | Duke University|Genentech, Inc.|Schering-Plough | Glioblastoma|Gliosarcoma|Brain Tumor | 2007-07 | PHASE2 |
| NCT01193595 | Sanofi | Neoplasms, Malignant | 2010-09 | PHASE1 |
| NCT02530801 | University of Nottingham | Recurrent Pterygium | 2017-01 | PHASE4 |
| NCT01777412 | Johns Hopkins University|Genentech, Inc.|Guthy Jackson Charitable Foundation | Neuromyelitis Optica|Neuromyelitis Optica Spectrum Disorder | 2013-06 | PHASE1 |
| NCT06788171 | Fujian Cancer Hospital | Colorectal Cancer Liver Metastasis | 2025-03-01 | PHASE2 |
| NCT01860586 | Wills Eye | Retinal Detachment|Vitreoretinopathy Proliferative | 2013-06 | NA |
| NCT02796183 | Neon Hospital|Ondokuz May?s University | Diabetic Macular Edema | 2015-01 | NA |
| NCT07564141 | Genmab | Platinum-Sensitive Ovarian Cancer|Ovarian Cancer | 2026-07 | PHASE3 |
| NCT00520975 | National Cancer Institute (NCI) | Breast Carcinoma|Recurrent Breast Carcinoma|Stage IV Breast Cancer | 2007-11 | PHASE3 |
| NCT01700400 | Cancer Research and Biostatistics Clinical Trials Consortium|University of Arizona|Providence Cancer Center, Earle A. Chiles Research Institute|Novartis Pharmaceuticals | Non Small Cell Lung Cancer | 2012-09 | PHASE1 |
| NCT00923936 | National Cancer Institute (NCI) | Sarcoma, Kaposi | 2009-04-23 | PHASE2 |
| NCT00600301 | Asociación para Evitar la Ceguera en México | Diffuse Diabetic Macular Edema | 2008-01 | PHASE3 |
| NCT01836536 | Center Eugene Marquis | Glioblastoma|Glioma | 2012-09 | NA |
| NCT00301964 | National Cancer Institute (NCI)|Gynecologic Oncology Group | Recurrent Endometrial Carcinoma | 2006-03 | PHASE2 |
| NCT06530251 | Akeso | Hepatocellular Carcinoma | 2024-09-24 | PHASE1|PHASE2 |
| NCT05824975 | GI Innovation, Inc.|Merck Sharp & Dohme LLC | Advanced Solid Tumor|Metastatic Solid Tumor|Soft Tissue Sarcoma (STS)|Platinum-resistant Ovarian Cancer (PROC)|Hepatocellular Carcinoma (HCC)|Colorectal Cancer (CRC)|HER2 Negative Breast Cancer|Cutaneous Melanoma|Renal Cell Carcinoma (RCC) | 2023-05-30 | PHASE1|PHASE2 |
| NCT05886465 | Sun Yat-sen University | Hepatocellular Carcinoma | 2023-05-24 | PHASE2 |
| NCT00118105 | SWOG Cancer Research Network|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group | Colorectal Cancer|Metastatic Cancer | 2006-11 | PHASE2 |
| NCT06245356 | UNICANCER|Servier | Metastatic Colorectal Cancer|Metastatic Gastroesophageal Adenocarcinoma|DPD Deficiency | 2025-03-21 | PHASE2 |
| NCT00335829 | Yale University|National Cancer Institute (NCI)|Northwestern University | Liver Cancer | 2006-05 | PHASE2 |
| NCT01229202 | Nova Scotia Health Authority | Glaucoma | 2008-07 | PHASE4 |
| NCT05284539 | Hunan Province Tumor Hospital | Non Small Cell Lung Cancer | 2022-04-01 | PHASE2 |
| NCT00898794 | Kantonsspital Graubuenden | Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific | 2007-10 | |
| NCT05238831 | OHSU Knight Cancer Institute|Genentech, Inc.|Oregon Health and Science University | Advanced Breast Carcinoma|Advanced Malignant Solid Neoplasm|Advanced Ovarian Carcinoma|Advanced Pancreatic Carcinoma|Advanced Prostate Carcinoma|Advanced Sarcoma|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Recurrent Adult Soft Tissue Sarcoma|Recurrent Breast Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Prostate Carcinoma|Stage II Pancreatic Cancer AJCC v8|Stage III Ovarian Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8 | 2023-01-30 | EARLY_PHASE1 |
| NCT04788381 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Colorectal Cancer|Lung Cancer|Operation Wound; Infection|Bevacizumab | 2021-04-01 | |
| NCT00859222 | Patrick Y. Wen, MD|Brigham and Women´s Hospital|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Northwestern University|University of Virginia|Genentech, Inc.|Novartis | Malignant Glioma | 2009-03 | PHASE1|PHASE2 |
| NCT01067053 | Grupo Espanol Multidisciplinario del Cancer Digestivo | Metastatic Colorectal Cancer | 2009-11 | PHASE2 |
| NCT06683703 | Beijing Biostar Pharmaceuticals Co., Ltd. | Non-small Cell Lung Cancer Patients with Brain Metastases | 2024-12-01 | PHASE2 |
| NCT00055861 | National Cancer Institute (NCI) | Recurrent Breast Cancer|Stage IV Breast Cancer | 2002-07 | PHASE2 |
| NCT00361231 | Massachusetts General Hospital|Genentech, Inc.|Sanofi|Beth Israel Deaconess Medical Center|Brigham and Women´s Hospital|Dana-Farber Cancer Institute | Biliary Tract Cancer|Gallbladder Adenocarcinoma | 2006-05 | PHASE2 |
| NCT01496742 | Genentech, Inc. | Non-Squamous Non-Small Cell Lung Cancer | 2012-04 | PHASE2 |
| NCT00378573 | Sanofi | Non-small Cell Lung Cancer | 2007-01 | PHASE2 |
| NCT01389505 | Instituto do Coracao|Coordena??o de Aperfei?oamento de Pessoal de Nível Superior. | Proliferative Diabetic Retinopathy | 2011-02 | PHASE2 |
| NCT00623805 | Hoffmann-La Roche | Colorectal Cancer | 2008-03 | PHASE3 |
| NCT04723004 | Shanghai Junshi Bioscience Co., Ltd. | Advanced Hepatocellular Carcinoma (HCC) | 2020-10-15 | PHASE3 |
| NCT00861419 | Amgen | Advanced Solid Tumors | 2005-12 | PHASE1 |
| NCT00577109 | Hoffmann-La Roche|Merck KGaA, Darmstadt, Germany | Colorectal Cancer | 2007-12 | PHASE2 |
| NCT07549399 | Sixth Affiliated Hospital, Sun Yat-sen University | Rectal Adenocarcinoma|High-Risk Cancer|MSS | 2026-04-30 | PHASE3 |
| NCT02250599 | Sun Yat-sen University | Nasopharyngeal Neoplasms | 2014-08 | PHASE2 |
| NCT07222800 | Pfizer | Intestinal Neoplasms|Gastrointestinal Neoplasms|Digestive System Neoplasms|Neoplasms by Site|Digestive System Diseases|Gastrointestinal Diseases|Colonic Diseases|Intestinal Diseases|Rectal Diseases|Colorectal Neoplasms | 2025-12-11 | PHASE3 |
| NCT00406744 | Asociación para Evitar la Ceguera en México | Age Related Macular Degeneration|Choroidal Neovascularization | 2006-05 | PHASE3 |
| NCT05919264 | Parabilis Medicines, Inc. | Cancer|Colorectal Cancer|Solid Tumor|Locally Advanced Solid Tumor|Metastatic Cancer|WNT Pathway|HCC|Desmoid|Microsatellite Stable Colorectal Cancer|Metastatic Castration-resistant Prostate Cancer|FAP|Endometrial Carcinoma|Prostate Cancer|Microsatellite Instability-High Colorectal Cancer|Adamantinomatous Craniopharyngioma | 2023-05-23 | PHASE1|PHASE2 |
| NCT01135498 | Hoffmann-La Roche | Colorectal Cancer | 2006-11 | PHASE2 |
| NCT01146795 | Jason D. Wright|Genentech, Inc. | Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer | 2010-05-17 | PHASE2 |
| NCT00127036 | H. Lee Moffitt Cancer Center and Research Institute|Roche Pharma AG | Adenocarcinoma|Colon Cancer | 2003-10 | PHASE2 |
| NCT00904852 | Millennium Pharmaceuticals, Inc. | Glioblastoma Multiforme | 2009-06 | PHASE1 |
| NCT00142467 | Massachusetts General Hospital|Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Brigham and Women´s Hospital|Genentech, Inc.|Sanofi-Synthelabo|Eli Lilly and Company | Hepatocellular Carcinoma | 2004-04 | PHASE2 |
| NCT01206530 | Abramson Cancer Center at Penn Medicine | Rectal Cancer|Colon Cancer|Metastasis|Adenocarcinoma | 2010-09 | PHASE1|PHASE2 |
| NCT00305877 | National Cancer Institute (NCI) | Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer | 2006-02 | PHASE2 |
| NCT00112528 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Pancreatic Cancer | 2005-06 | PHASE2 |
| NCT04250064 | Tata Memorial Centre | DIPG | 2020-02-04 | PHASE2 |
| NCT05593328 | Cardiff Oncology | Colorectal Cancer|Metastatic Colorectal Cancer | 2023-03-17 | PHASE2 |
| NCT00409565 | National Cancer Institute (NCI) | Head and Neck Cancer|Squamous Cell Carcinoma | 2006-09 | PHASE2 |
| NCT01051934 | National Cancer Institute (NCI) | Non-Small Cell Lung Cancer|Adenocarcinoma | 2009-12-29 | PHASE1 |
| NCT01792934 | Radboud University Medical Center|Erasmus Medical Center | Multi-organ Metastatic Colorectal Cancer | 2013-05 | NA |
| NCT06139211 | Shanghai Junshi Bioscience Co., Ltd.|Sponsor GmbH | Advanced Solid Tumor | 2024-01-03 | PHASE1|PHASE2 |
| NCT00271609 | National Cancer Institute (NCI) | Recurrent High-Grade Gliomas|Malignant Gliomas | 2005-12 | PHASE2 |
| NCT01679327 | Chinese Academy of Medical Sciences | Colorectal Cancer | 2012-03 | PHASE2 |
| NCT02312245 | Mayo Clinic|National Cancer Institute (NCI) | Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma | 2015-07-21 | PHASE2 |
| NCT07392866 | Nanjing Sanhome Pharmaceutical, Co., Ltd. | Hepatocellular Carcinoma (HCC) | 2026-03-01 | PHASE2|PHASE3 |
| NCT05970666 | The First Affiliated Hospital of Xiamen University|Jiangsu HengRui Medicine Co., Ltd. | Adebrelimab|Hepatocellular Carcinoma|Transformation|Bevacizumab|TACE | 2023-11-15 | PHASE2 |
| NCT00403403 | Genentech, Inc. | Small Cell Lung Cancer | 2007-03 | PHASE2 |
| NCT06576037 | M.D. Anderson Cancer Center | Solid Tumor | 2024-10-31 | PHASE1 |
| NCT01471470 | Asan Medical Center|Roche Pharma AG | Advanced Gastric Cancer | 2010-07 | PHASE2 |
| NCT06540729 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Ovary Cancer | 2024-09-24 | PHASE2 |
| NCT01338753 | Clinica Universidad de Navarra, Universidad de Navarra|Roche Farma, S.A | Breast Neoplasms | 2009-10 | PHASE2 |
| NCT00667394 | National Cancer Institute (NCI) | Glioblastoma|Gliosarcoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Mixed Oligoastrocytoma | 2008-04 | PHASE2 |
| NCT00119262 | National Cancer Institute (NCI) | Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer | 2005-10 | PHASE2 |
| NCT04803994 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Hepatocellular Carcinoma | 2021-07-06 | PHASE3 |
| NCT06447662 | Pfizer | Carcinoma, Pancreatic Ductal|Colorectal Neoplasms|Carcinoma, Non-Small-Cell Lung | 2024-06-27 | PHASE1 |
| NCT03390686 | Prestige Biopharma Limited | Lung Cancer|Non-small Cell Lung Cancer | 2019-11-15 | PHASE3 |
| NCT00360360 | SCRI Development Innovations, LLC|Genentech, Inc. | Neoplasm, Unknown Primary | 2006-07 | PHASE2 |
| NCT02036723 | Biocad | Wet Age-related Macular Degeneration | | PHASE3 |
| NCT04854668 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Metastatic Colorectal Cancer | 2021-05-27 | PHASE3 |
| NCT00501891 | Duke University|Genentech, Inc.|Schering-Plough | Glioblastoma Multiforme | 2007-07 | PHASE2 |
| NCT02036424 | Raj K. Maturi, MD|Allergan | Diabetic Macular Edema | 2014-01 | PHASE4 |
| NCT04194203 | Hoffmann-La Roche | Carcinoma, Non-Small-Cell Lung | 2020-04-09 | PHASE3 |
| NCT01069796 | ARCAGY+ GINECO GROUP | Triple Negative Metastatic Breast Cancer | 2010-04 | PHASE2 |
| NCT01664182 | National Cancer Institute (NCI) | Advanced Renal Cell Carcinoma|Advanced Sarcomatoid Renal Cell Carcinoma|Stage III Renal Cell Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7 | 2012-08-01 | PHASE2 |
| NCT00267696 | Ohio State University Comprehensive Cancer Center|Genentech, Inc.|Eli Lilly and Company | Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer | 2005-11 | PHASE2 |
| NCT01091896 | University of Sao Paulo | Vitreous Hemorrhage Secondary to PDR | 2010-01 | PHASE2 |
| NCT00642603 | Hoffmann-La Roche | Colorectal Cancer | 2008-05 | PHASE2 |
| NCT06313970 | Fudan University | Pancreatic Cancer | 2024-06-20 | PHASE2 |
| NCT00017394 | National Cancer Institute (NCI) | Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer | 2001-03 | PHASE2 |
| NCT00774241 | Hoffmann-La Roche | Breast Cancer | 2010-01 | PHASE4 |
| NCT00720356 | Northwestern University|M.D. Anderson Cancer Center | Brain and Central Nervous System Tumors | 2009-07-07 | PHASE2 |
| NCT02363751 | UNICANCER | Collecting Duct Carcinoma (Kidney) | 2014-12 | PHASE2 |
| NCT00520403 | Hoffmann-La Roche | Renal Cell Cancer | 2007-09 | PHASE2 |
| NCT06329570 | NaviFUS Corporation|NaviFUS US LLC | Glioblastoma Multiforme|Glioblastoma|Glioma|Brain Tumor|Neoplasms|Neoplasms, Nerve Tissue | 2024-10-22 | PHASE1|PHASE2 |
| NCT00426829 | M.D. Anderson Cancer Center|Genentech, Inc. | Liver Cancer|Hepatocellular Carcinoma|Cholangiocarcinoma | 2007-05 | PHASE1 |
| NCT04446416 | NaviFUS Corporation|Chang Gung Memorial Hospital | Glioblastoma Multiforme|Glioblastoma|Glioma|Brain Tumor|Neoplasms|Neoplasms, Nerve Tissue | 2020-07-21 | NA |
| NCT00528567 | Hoffmann-La Roche | Breast Cancer | 2007-12 | PHASE3 |
| NCT00095706 | Translational Oncology Research International|Genentech, Inc. | Breast Cancer | 2003-06 | PHASE1|PHASE2 |
| NCT02884648 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Malignant Neoplasms of Female Genital Organs|Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer | 2016-11-15 | PHASE2 |
| NCT01283048 | Toni Choueiri, MD|Beth Israel Deaconess Medical Center | Renal Cell Carcinoma | 2011-09 | PHASE1 |
| NCT02308644 | University of Sao Paulo | Diabetic Macular Edema | 2009-02 | PHASE3 |
| NCT05585814 | Shanghai Changzheng Hospital | Locally Advanced Colorectal Cancer | 2023-05-01 | PHASE2 |
| NCT06952452 | Parc de Salut Mar|Instituto de Salud Carlos III | Wet Age-related Macular Degeneration | 2022-11-18 | PHASE3 |
| NCT00077298 | National Cancer Institute (NCI) | Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer | 2003-12 | PHASE2 |
| NCT02305758 | AbbVie | Untreated Metastatic Colorectal Cancer | 2014-12-02 | PHASE2 |
| NCT00867321 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Liver Cancer | 2009-04 | PHASE1|PHASE2 |
| NCT00347698 | Asociación para Evitar la Ceguera en México | Diabetic Retinopathy | 2006-03 | PHASE2|PHASE3 |
| NCT04135898 | Shanghai Institute Of Biological Products | Healthy Male | 2019-10-23 | PHASE1 |
| NCT02339116 | Gruppo Oncologico del Nord-Ovest | Metastatic Colorectal Cancer | 2015-02-26 | PHASE3 |
| NCT00378638 | Chap, Linnea I., M.D.|Genentech, Inc. | Breast Cancer | 2006-06 | PHASE2 |
| NCT03890952 | Ulrik Lassen|Herlev Hospital|University of Copenhagen | Recurrent Adult Brain Tumor | 2018-10-01 | PHASE2 |
| NCT05525858 | Seoul National University Bundang Hospital|Korean Cancer Study Group|Roche Pharma AG | Solid Tumor|Advanced Solid Tumor|Metastatic Cancer | 2022-09-28 | |
| NCT00262847 | National Cancer Institute (NCI)|NRG Oncology | Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Malignant Ovarian Mixed Epithelial Tumor|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Primary Peritoneal Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Primary Peritoneal Cancer|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer|Undifferentiated Fallopian Tube Carcinoma|Undifferentiated Ovarian Carcinoma | 2005-09 | PHASE3 |
| NCT05118776 | Ascletis Pharmaceuticals Co., Ltd. | Recurrent Glioblastoma | 2022-01-21 | PHASE3 |
| NCT01831089 | PharmaMar | Breast Cancer|Ovarian Cancer|Gynecological Cancer|Head and Neck Carcinoma|Non-small Cell Lung Cancer|Small Cell Lung Cancer|Non-squamous Cell Lung Cancer | 2013-09 | PHASE1 |
| NCT00957125 | Thomas Hatschek | Breast Cancer | 2008-09 | PHASE2 |
| NCT01443676 | University of Zurich | Glioblastoma | 2011-10 | PHASE2 |
| NCT01932125 | Hoffmann-La Roche | Ovarian Neoplasms|Peritoneal Neoplasms|Fallopian Tube Neoplasms | 2018-12-05 | PHASE4 |
| NCT01722968 | Theodoros Foukakis | Breast Cancer | 2012-11 | PHASE2 |
| NCT01910610 | GERCOR - Multidisciplinary Oncology Cooperative Group|Hoffmann-La Roche | Colorectal Cancer Metastatic | 2013-10-30 | PHASE3 |
| NCT01305213 | National Cancer Institute (NCI)|NRG Oncology | Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma | 2011-03-21 | PHASE2 |
| NCT00334763 | Northwestern University|National Cancer Institute (NCI) | Lung Cancer | 2006-05 | PHASE2 |
| NCT03654833 | University of Leicester|British Lung Foundation|Clovis Oncology, Inc.|Eli Lilly and Company|Merck Sharp & Dohme LLC|BerGenBio ASA|Roche Pharma AG|University Hospitals, Leicester|The Christie NHS Foundation Trust|GlaxoSmithKline | Mesothelioma, Malignant | 2019-01-28 | PHASE2 |
| NCT03798626 | Novartis Pharmaceuticals | Colorectal Cancer|Gastroesophageal Cancer|Renal Cell Carcinoma | 2019-05-22 | PHASE1 |
| NCT06445062 | Revolution Medicines, Inc. | Colorectal Cancer|CRC|Pancreatic Ductal Adenocarcinoma|PDAC|Gastrointestinal Cancer|Metastatic Pancreatic Ductal Adenocarcinoma | 2024-05-24 | PHASE1|PHASE2 |
| NCT02754882 | Samsung Bioepis Co., Ltd. | Lung Cancer|Non-small Cell Lung Cancer | 2016-07-05 | PHASE3 |
| NCT07391566 | Luye Pharma Group Ltd. | Metastatic Colorectal Cancer (mCRC) | 2026-03-31 | PHASE1|PHASE2 |
| NCT01107626 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI) | Lung Cancer | 2010-10-25 | PHASE3 |
| NCT03732235 | Giammaria Fiorentini | Liver Metastasis Colon Cancer | 2018-10-01 | |
| NCT01089413 | Hoffmann-La Roche | Colorectal Cancer | 2010-01 | |
| NCT04138420 | Federico II University | Exudative Age-related Macular Degeneration | 2017-01-25 | |
| NCT01115491 | Hoffmann-La Roche | Glioblastoma Multiforme | 2010-06 | PHASE2 |
| NCT00088894 | National Cancer Institute (NCI) | Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer | 2004-06 | PHASE3 |
| NCT05863195 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI) | Metastatic Colorectal Carcinoma|Metastatic Malignant Neoplasm in the Liver|Stage IV Colorectal Cancer AJCC v8|Unresectable Colorectal Carcinoma | 2023-10-19 | PHASE3 |
| NCT00610493 | M.D. Anderson Cancer Center | Advanced Cancer | 2008-01-25 | PHASE1 |
| NCT01508000 | European Organisation for Research and Treatment of Cancer - EORTC|Amgen|Roche Pharma AG | Colorectal Cancer Metastatic|Liver Metastases|KRAS Wild Type Colorectal Cancer | 2013-06 | PHASE2 |
| NCT03609307 | Shahid Beheshti University of Medical Sciences | Age Related Macular Degeneration | 2018-09 | PHASE2|PHASE3 |
| NCT06881537 | Shanghai Changzheng Hospital | Locally Recurrent Colorectal Cancer | 2024-06-01 | PHASE2 |
| NCT00323869 | Stanford University|Eli Lilly and Company|Genentech, Inc. | Lung Cancer|Non-small Cell Lung Cancer (NSCLC) | 2006-06 | PHASE2 |
| NCT01487629 | University of Sao Paulo|Funda??o de Amparo à Pesquisa do Estado de S?o Paulo | Diabetic Retinopathy|Macular Edema | 2010-04 | PHASE2 |
| NCT00126542 | National Cancer Institute (NCI) | Fallopian Tube Cancer|Primary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer | 2005-04 | PHASE2 |
| NCT00777673 | University of Tennessee Cancer Institute|National Comprehensive Cancer Network|Celgene Corporation|Genentech, Inc. | Breast Cancer | 2008-10 | PHASE2 |
| NCT00015951 | University of Maryland, Baltimore|National Cancer Institute (NCI)|University of Maryland Greenebaum Cancer Center | Leukemia|Myelodysplastic Syndromes | 2001-04 | PHASE2 |
| NCT00308529 | SCRI Development Innovations, LLC|Genentech, Inc. | Carcinoma, Small Cell Lung|Lung Cancer | 2006-03 | PHASE2 |
| NCT04511715 | Shahid Beheshti University of Medical Sciences | Non-proliferative Diabetic Retinopathy | 2020-09-01 | PHASE2|PHASE3 |
| NCT00517595 | Accelerated Community Oncology Research Network|Eli Lilly and Company|Genentech, Inc. | Non-Small Cell Lung Cancer | 2007-08 | PHASE2 |
| NCT07058428 | Sun Yat-Sen University Cancer Center | Multiple Brain Metastases in Lung Adenocarcinoma | 2025-06-30 | PHASE3 |
| NCT00590681 | University of Chicago|Genentech, Inc. | Glioblastoma Multiforme | 2007-02 | PHASE2 |
| NCT00016094 | National Cancer Institute (NCI) | Anaplastic Large Cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Mantle Cell Lymphoma | 2001-04 | PHASE2 |
| NCT03169777 | ImmunityBio, Inc. | Colorectal Cancer | 2018-08 | PHASE1|PHASE2 |
| NCT03743428 | Shenzhen People´s Hospital | Colorectal Neoplasms | 2020-10-22 | NA |
| NCT00614653 | M.D. Anderson Cancer Center|Genentech, Inc. | Pancreatic Cancer | 2008-01 | PHASE1 |
| NCT05757336 | Lu Wang, MD, PhD | Gallbladder Cancer|Initially Unresectable|the First Line Treatment | 2022-12-22 | PHASE2 |
| NCT04952753 | Novartis Pharmaceuticals | Metastatic Colorectal Cancer | 2021-11-15 | PHASE2 |
| NCT05290948 | Shahid Beheshti University of Medical Sciences | Macular Edema | 2022-03-12 | PHASE2 |
| NCT00571740 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Colorectal Cancer | | PHASE2 |
| NCT00491738 | Genentech, Inc. | Renal Cell Carcinoma | 2007-08 | PHASE2 |
| NCT05717738 | Tongji Hospital|Chinese Cooperative Group of Liver Cancer|Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei Province|The Second Affiliated Hospital of Fujian Medical University|Geneplus-Beijing Co. Ltd.|Haplox Biotechnology Co., Ltd. | Hepatocellular Carcinoma Non-resectable | 2022-01-20 | |
| NCT01131078 | Hoffmann-La Roche | Colorectal Cancer | 2005-06 | PHASE2 |
| NCT00468585 | Memorial Sloan Kettering Cancer Center | Breast Cancer | 2005-06 | PHASE1|PHASE2 |
| NCT00737243 | SCRI Development Innovations, LLC|Genentech, Inc. | Carcinoma | 2008-08 | PHASE2 |
| NCT00352521 | Duke University|National Cancer Institute (NCI) | Brain and Central Nervous System Tumors | 2006-04 | PHASE2 |
| NCT05191784 | Genexine, Inc. | Recurrent Glioblastoma | 2022-01-26 | PHASE2 |
| NCT07059949 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Unresectable Metastatic Rectal Cancer|CAPOX|Combination of Radioimmunotherapy | 2025-06-30 | PHASE2 |
| NCT00305825 | University of California, San Francisco|National Cancer Institute (NCI)|Memorial Sloan Kettering Cancer Center | Breast Cancer | 2004-08 | PHASE2 |
| NCT06497985 | Chipscreen Biosciences, Ltd. | Colorectal Cancer | 2024-12-06 | PHASE3 |
| NCT00288015 | Northwestern University|Genentech, Inc. | Sarcoma | 2005-10 | PHASE2 |
| NCT00959647 | Genentech, Inc. | Ovarian Cancer|Basal Cell Carcinoma|Metastatic Colorectal Cancer | 2009-09-03 | PHASE2 |
| NCT01004250 | Eli Lilly and Company | Non-Small Cell Lung Cancer | 2009-10 | PHASE2 |
| NCT02342379 | The University of Texas Health Science Center at San Antonio | Glioblastoma | 2015-05 | PHASE2 |
| NCT00866723 | Beth Israel Deaconess Medical Center|Dana-Farber Cancer Institute|Massachusetts General Hospital|Genentech, Inc. | Ovarian Cancer|Primary Peritoneal Serous Cancer|Fallopian Tube Cancer | 2009-03 | PHASE2 |
| NCT07497074 | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Cervical Cancer | 2026-04 | PHASE2 |
| NCT00881751 | Medical University of South Carolina | Liver Cancer | 2009-03 | PHASE2 |
| NCT02923739 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Fallopian Tube Adenocarcinoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Fallopian Tube Undifferentiated Carcinoma|Malignant Ovarian Brenner Tumor|Ovarian Adenocarcinoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Ovarian Undifferentiated Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma | 2017-05-05 | PHASE2 |
| NCT03834753 | Outlook Therapeutics, Inc. | Age-related Macular Degeneration|Neovascular Age-related Macular Degeneration|Wet Macular Degeneration | 2019-06-25 | PHASE3 |
| NCT00850577 | Bristol-Myers Squibb | Non-small Cell Lung Cancer (NSCLC) | 2009-06 | PHASE2 |
| NCT01321957 | Martin-Luther-Universit?t Halle-Wittenberg|Roche Pharma AG | Metastatic Colorectal Cancer | 2011-05 | PHASE2 |
| NCT00977574 | National Cancer Institute (NCI)|NRG Oncology | Endometrial Adenocarcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Recurrent Malignant Uterine Corpus Neoplasm|Stage IIIA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage|Stage IIIB Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage|Stage IIIC Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage|Stage IVA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage|Stage IVB Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage | 2009-09-14 | PHASE2 |
| NCT01327222 | IRCCS San Raffaele | Age Related Macular Degeneration | 2011-02 | PHASE3 |
| NCT00569127 | National Cancer Institute (NCI) | Colorectal Neuroendocrine Tumor G1|Gastric Neuroendocrine Tumor G1|Neuroendocrine Neoplasm|Neuroendocrine Tumor|Neuroendocrine Tumor G2 | 2007-12-01 | PHASE3 |
| NCT03462251 | iOMEDICO AG|Novartis Pharmaceuticals | Breast Cancer|Hormone Receptor Positive Tumor|HER 2 Negative Breast Cancer | 2018-05-24 | PHASE3 |
| NCT06512051 | Shanghai Hengrui Pharmaceutical Co., Ltd. | Advanced or Metastatic Non-small Cell Lung Cancer | 2024-07-30 | PHASE1|PHASE2 |
| NCT05843188 | University Health Network, Toronto | Metastatic Colorectal Cancer | 2023-08-09 | PHASE2 |
| NCT00659022 | Radboud University Medical Center | Colorectal Neoplasms|Liver Neoplasms | 2008-07 | PHASE2 |
| NCT00378703 | National Cancer Institute (NCI) | Clear Cell Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Stage IV Renal Cell Cancer AJCC v7 | 2007-09-14 | PHASE2 |
| NCT07216703 | Merck Sharp & Dohme LLC|European Network of Gynaecological Oncological Trial Groups (ENGOT)|GOG Foundation | Cervical Cancer | 2026-01-19 | PHASE3 |
| NCT07111546 | Nanjing Leads Biolabs Co.,Ltd|Shanghai Zhongshan Hospital | Advanced Solid Tumour | 2025-10-20 | PHASE2 |
| NCT03401294 | University of Saskatchewan | Metastatic Colorectal Cancer | 2025-05-01 | PHASE2 |
| NCT00423059 | Yonsei University | Diabetic Retinopathy | 2006-12 | NA |
| NCT00843440 | Hospices Civils de Lyon | Hemorrhagic Hereditary Telangiectasia | 2009-03 | PHASE2 |
| NCT00393497 | Indiana University | Breast Cancer|Lymphedema | 2007-04 | PHASE1 |
| NCT01950390 | National Cancer Institute (NCI) | Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Unresectable Melanoma | 2014-01-24 | PHASE2 |
| NCT01739218 | Hoffmann-La Roche | Ovarian Cancer | 2013-02-01 | PHASE2 |
| NCT07186868 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Recurrent Cervical Cancer|Metastatic Cervical Cancer | 2025-10-15 | |
| NCT00460174 | Northwestern University|National Cancer Institute (NCI) | Pancreatic Cancer | 2005-10-10 | PHASE2 |
| NCT04607421 | Pfizer|Ono Pharmaceutical Co., Ltd.|Merck KGaA, Darmstadt, Germany|Eli Lilly and Company | Neoplasms | 2020-12-21 | PHASE3 |
| NCT07293468 | Tuen Mun Hospital|Queen Mary Hospital, Hong Kong|The University of Hong Kong|The University of Hong Kong-Shenzhen Hospital | Hepatocellular Carcinoma (HCC) | 2024-04-01 | PHASE2|PHASE3 |
| NCT05836324 | Incyte Corporation | Solid Tumors|Advanced Solid Tumors|Metastatic Solid Tumors | 2023-07-24 | PHASE1 |
| NCT07324824 | Sun Yat-sen University | Hepatocellular Carcinoma|Neoadjuvant Therapy|Sintilimab|Bevacizimab | 2026-01-14 | PHASE2 |
| NCT06060704 | The First Affiliated Hospital with Nanjing Medical University | Metastatic Colorectal Cancer | 2023-11 | PHASE2 |
| NCT02187302 | NewLink Genetics Corporation | Metastatic Renal Cell Carcinoma | 2014-07 | PHASE2 |
| NCT00406172 | Asociación para Evitar la Ceguera en México | Cystoid Macular Edema | 2006-11 | PHASE3 |
| NCT00025337 | National Cancer Institute (NCI) | Adenocarcinoma of the Colon|Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage III Colon Cancer|Stage III Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal Cancer | 2001-09 | PHASE3 |
| NCT04940546 | Sun Yat-sen University | Colorectal Cancer Metastatic | 2021-06-16 | PHASE1|PHASE2 |
| NCT02753127 | Sumitomo Pharma America, Inc. | Colorectal Cancer | 2016-06 | PHASE3 |
| NCT00580333 | Massachusetts General Hospital|Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Brigham and Women´s Hospital|Genentech, Inc. | Breast Cancer | 2007-09 | PHASE2 |
| NCT07527858 | Gilead Sciences | Advanced Microsatellite Stable Colorectal Cancer | 2026-04 | PHASE2 |
| NCT06682247 | Feng Wang | Colorectal Cancer Metastatic | 2024-11-15 | |
| NCT01120158 | Hellenic Oncology Research Group|University Hospital of Crete | Breast Cancer | 2009-09 | PHASE2 |
| NCT04725448 | Sichuan Cancer Hospital and Research Institute | Pulmonary Sarcomatoid Carcinoma|Non-small Cell Lung Cancer|Lung Diseases|Thoracic Neoplasms | 2021-04-06 | PHASE2 |
| NCT01114555 | Memorial Sloan Kettering Cancer Center|Genentech, Inc. | Neuroblastoma | 2010-04-29 | PHASE2 |
| NCT00022048 | Stanford University|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 2001-08 | PHASE1|PHASE2 |
| NCT07466238 | Peking University | Biliary Tract Cancer (BTC) | 2026-03-31 | NA |
| NCT01063283 | University of Chicago|Genentech, Inc. | Advanced Non-squamous Non-Small Cell Lung Cancer | 2010-03 | NA |
| NCT00324870 | National Cancer Institute (NCI) | Clear Cell Renal Cell Carcinoma|Recurrent Renal Cell Cancer|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer | 2006-02 | PHASE1|PHASE2 |
| NCT02200354 | Kobe City General Hospital | Advanced Non-small Cell Lung Cancer | 2014-07 | PHASE2 |
| NCT00405405 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University|Genentech, Inc. | Head and Neck Cancer|Parotid Gland Cancer|Thyroid Gland Cancer|Melanoma|Stage IV Head and Neck Cancer | 2006-12 | PHASE1 |
| NCT06878196 | Obstetrics & Gynecology Hospital of Fudan University | Uterine Cervical Neoplasm | 2025-03-10 | NA |
| NCT02139579 | Sun Yat-sen University|First Affiliated Hospital, Sun Yat-Sen University|Second Affiliated Hospital, Sun Yat-Sen University | Lung, Carcinoma | 2014-05 | PHASE2 |
| NCT01989780 | Japan Breast Cancer Research Group|Chugai Pharmaceutical | Metastatic Breast Cancer | 2014-01 | PHASE2 |
| NCT01621880 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Nasopharyngeal Carcinoma|Adverse Effect of Radiation Therapy|Brain Necrosis | 2012-06 | PHASE2 |
| NCT06361979 | Huihua Xiong | Breasr Cancer | 2024-05 | PHASE2 |
| NCT06096779 | Genentech, Inc. | Hepatocellular Carcinoma | 2024-07-15 | PHASE2 |
| NCT01306591 | Peking University People´s Hospital | Exudative Age-related Macular Degeneration | 2008-01 | NA |
| NCT04929223 | Hoffmann-La Roche | Metastatic Colorectal Cancer | 2021-10-22 | PHASE1 |
| NCT00879359 | The Cleveland Clinic|Genentech, Inc. | Endometrial Carcinoma | 2007-12 | PHASE2 |
| NCT07560488 | Tianjin Medical University Cancer Institute and Hospital | HCC - Hepatocellular Carcinoma|Conversion Therapy | 2026-03-30 | PHASE2 |
| NCT05584670 | Sanofi | Solid Tumor | 2022-11-29 | PHASE1|PHASE2 |
| NCT01219205 | Hallym University Medical Center | Macular Edema | 2008-03 | NA |
| NCT03387111 | ImmunityBio, Inc. | Squamous Cell Carcinoma | 2018-01-09 | PHASE1|PHASE2 |
| NCT01095809 | Hospital Clinic of Barcelona | Uveitis | 2010-04 | PHASE3 |
| NCT00234052 | Northwestern University|National Cancer Institute (NCI) | Lung Cancer | 2005-07-28 | PHASE2 |
| NCT05636111 | M.D. Anderson Cancer Center|Jazz Pharmaceuticals | Ovarian Cancer | 2023-07-12 | PHASE1 |
| NCT06755684 | Peng Zhang | EGFR|Non-Small Cell Lung Cancer|Locally Advanced Non-Small Cell Lung Cancer|Pemetrexed|Carboplatin|Bevacizumab|Antineoplastic Agents|Tyrosine Kinase Inhibitor | 2024-11-07 | PHASE2 |
| NCT05063552 | National Cancer Institute (NCI) | Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8|Metastatic Head and Neck Squamous Cell Carcinoma|Metastatic Hypopharyngeal Squamous Cell Carcinoma|Metastatic Laryngeal Squamous Cell Carcinoma|Metastatic Lip and Oral Cavity Carcinoma|Metastatic Nasal Cavity Squamous Cell Carcinoma|Metastatic Nasopharyngeal Squamous Cell Carcinoma|Metastatic Pharyngeal Squamous Cell Carcinoma|Metastatic Sinonasal Squamous Cell Carcinoma|Recurrent Head and Neck Squamous Cell Carcinoma|Recurrent Hypopharyngeal Squamous Cell Carcinoma|Recurrent Laryngeal Squamous Cell Carcinoma|Recurrent Lip and Oral Cavity Squamous Cell Carcinoma|Recurrent Nasopharyngeal Squamous Cell Carcinoma|Recurrent Pharyngeal Squamous Cell Carcinoma|Recurrent Sinonasal Squamous Cell Carcinoma|Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8|Stage IV Hypopharyngeal Carcinoma AJCC v8|Stage IV Laryngeal Cancer AJCC v8|Stage IV Lip and Oral Cavity Cancer AJCC v8|Stage IV Nasopharyngeal Carcinoma AJCC v8|Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8|Stage IV Sinonasal Cancer AJCC v8 | 2023-03-13 | PHASE2|PHASE3 |
| NCT04262687 | Federation Francophone de Cancerologie Digestive | Colorectal Cancer Metastatic|High Immune Infiltrate|Microsatellite Stable | 2021-04-06 | PHASE2 |
| NCT02076152 | Massachusetts General Hospital|National Cancer Institute (NCI) | Recurrent Glioblastoma | 2014-02 | NA |
| NCT00828009 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI) | Lung Cancer | 2011-01-17 | PHASE2 |
| NCT06448364 | Pfizer | Advanced or Metastatic Solid Tumors|Non-Small Cell Lung Cancer|Colorectal Cancer|Urothelial Cancer|Melanoma | 2024-05-09 | PHASE1 |
| NCT05030493 | Takeda | Colorectal Cancer | 2021-08-31 | |
| NCT02246049 | EPS Corporation | Colorectal Neoplasms | 2014-05 | PHASE2 |
| NCT01198548 | Roswell Park Cancer Institute|National Cancer Institute (NCI) | Stage IV Colon Cancer|Stage IV Rectal Cancer | 2010-08 | PHASE2 |
| NCT01368848 | Arbeitsgemeinschaft medikamentoese Tumortherapie|Sanofi|Roche Pharma AG | NSCLC | 2010-04 | PHASE2 |
| NCT00890786 | Children´s Hospital Medical Center, Cincinnati|Genentech, Inc. | Newly Diagnosed High-Grade Gliomas|Diffuse Intrinsic Pontine Glioma | 2009-05 | EARLY_PHASE1 |
| NCT04217954 | Peking University | Advanced Biliary Tract Cancer | 2020-07-28 | PHASE2 |
| NCT03133546 | ETOP IBCSG Partners Foundation|AstraZeneca|Hoffmann-La Roche | Non Small Cell Lung Cancer Metastatic | 2017-05-31 | PHASE2 |
| NCT00072566 | National Cancer Institute (NCI) | Primary Peritoneal Carcinoma|Recurrent Ovarian Carcinoma|Stage IV Ovarian Cancer | 2003-12 | PHASE2 |
| NCT01916447 | Taiho Oncology, Inc. | Advanced Gastrointestinal Tumors | 2013-09 | PHASE1 |
| NCT07204574 | Chang Gung Memorial Hospital|FBD Biologics Limited | CRC | 2025-05-14 | PHASE1|PHASE2 |
| NCT07193862 | Northwell Health | Colorectal Cancer Metastatic | 2025-12-10 | EARLY_PHASE1 |
| NCT02075086 | Grupo Hospital de Madrid | Colorectal Cancer | 2011-07 | PHASE2 |
| NCT03533127 | Luye Pharma Group Ltd. | Non Small Cell Lung Cancer|Non Small Cell Lung Cancer Metastatic|Non Small Cell Lung Cancer Recurrent | 2017-11-27 | PHASE3 |
| NCT01969708 | The Emmes Company, LLC|National Eye Institute (NEI)|Milton S. Hershey Medical Center|University of Wisconsin, Madison | Central Retinal Vein Occlusion | 2014-09 | PHASE3 |
| NCT00265824 | GERCOR - Multidisciplinary Oncology Cooperative Group | Colorectal Cancer | 2005-05 | PHASE3 |
| NCT00612586 | Eli Lilly and Company|Roche Pharma AG | Colorectal Cancer | 2008-02 | PHASE2 |
| NCT02819479 | Norton Healthcare|University of Kentucky | Radiation Necrosis | 2016-11-23 | PHASE2 |
| NCT00126503 | National Cancer Institute (NCI) | Chromophobe Renal Cell Carcinoma|Clear Cell Renal Cell Carcinoma|Papillary Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Sarcomatoid Renal Cell Carcinoma|Stage IV Renal Cell Cancer | 2005-05 | PHASE1|PHASE2 |
| NCT00968435 | Memorial Sloan Kettering Cancer Center|Genentech, Inc. | Head and Neck Cancer | 2009-08 | PHASE2 |
| NCT05785325 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Colorectal Cancer | 2023-08-20 | PHASE2 |
| NCT07318389 | M.D. Anderson Cancer Center | Dynamic Tumor Resistance|Metastatic Colorectal Cancer | 2026-06-10 | EARLY_PHASE1 |
| NCT05769010 | Henan Cancer Hospital | Metastatic Breast Cancer | 2023-03-31 | PHASE2 |
| NCT05819060 | Fudan University | Recurrent Ovarian Cancer | 2023-04-30 | PHASE2 |
| NCT03896074 | Fondazione Ricerca Traslazionale | Non-small-cell Lung Cancer Patients | 2020-03-02 | PHASE2 |
| NCT00531024 | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | Macular Degeneration | 2005-08 | PHASE2|PHASE3 |
| NCT05690048 | Michael Dill|National Center for Tumor Diseases, Heidelberg|German Cancer Research Center|Heidelberg University|University of Cologne|Universit?tsmedizin Mannheim | Immunotherapy|HCC - Hepatocellular Carcinoma | 2025-07-16 | PHASE2 |
| NCT01399190 | Hoffmann-La Roche | Colorectal Cancer | 2011-07 | |
| NCT07358520 | Fudan University | Proteinuria | 2026-01-28 | PHASE4 |
| NCT03912415 | Biocad | Cervical Cancer | 2019-10-01 | PHASE3 |
| NCT00800917 | Rigshospitalet, Denmark|University of Copenhagen|Wyeth is now a wholly owned subsidiary of Pfizer|Roche, Copenhagen | Glioblastoma Multiforme | 2008-11 | PHASE2 |
| NCT06737913 | Sun Yat-sen University|Henan Provincial People´s Hospital|First Affiliated Hospital of Fujian Medical University|Shanghai Zhongshan Hospital|Cancer Hospital of Guangxi Medical University | Advanced Hepatocellular Carcinoma (HCC) | 2025-01-03 | PHASE2 |
| NCT06543069 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Malignant Peritoneal Mesothelioma, Advanced | 2024-01-31 | PHASE2 |
| NCT00162669 | Gustave Roussy, Cancer Campus, Grand Paris|Hoffmann-La Roche | Hepatocellular Carcinoma | 2005-05 | PHASE2 |
| NCT04512430 | Fundación GECP | Non Small Cell Lung Cancer|EGFR Gene Mutation | 2020-12-02 | PHASE2 |
| NCT06393166 | Zhejiang Cancer Hospital | Non-Resectable Pancreas Carcinoma | 2023-05-01 | PHASE2 |
| NCT06202001 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Metastatic Colorectal Cancer | 2022-10-01 | PHASE1|PHASE2 |
| NCT01454102 | Bristol-Myers Squibb | Non-small Cell Lung Cancer | 2011-12-16 | PHASE1 |
| NCT00349557 | Benaroya Research Institute|Genentech, Inc. | Prostate Cancer | 2006-04 | PHASE2 |
| NCT03596281 | Gustave Roussy, Cancer Campus, Grand Paris | Ovarian Cancer | 2018-12-05 | PHASE1 |
| NCT00845910 | Hoffmann-La Roche | Breast Cancer | 2009-05 | PHASE2 |
| NCT06433869 | Sun Yat-sen University | Malignant Ascites | 2023-12-14 | PHASE2 |
| NCT06192680 | Harbin Medical University | Colorectal Cancer | 2024-04-01 | PHASE2 |
| NCT00626561 | M.D. Anderson Cancer Center|Genentech, Inc. | Cervical Cancer|Uterine Cancer | 2008-02 | PHASE2 |
| NCT00408070 | UConn Health|Genentech, Inc. | Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer|Stage 3 Cancer|Stage 4 Cancer | 2006-10 | PHASE2 |
| NCT00193622 | SCRI Development Innovations, LLC|Genentech, Inc. | Neoplasms, Unknown Primary | 2004-04 | PHASE2 |
| NCT06006286 | M.D. Anderson Cancer Center | Metastatic Hepatocellular Carcinoma | 2023-08-08 | PHASE1|PHASE2 |
| NCT03074513 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Appendix Adenocarcinoma|Human Papillomavirus-Related Anal Squamous Cell Carcinoma|Human Papillomavirus-Related Cervical Squamous Cell Carcinoma|Human Papillomavirus-Related Squamous Cell Carcinoma of the Penis|Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma|Neuroendocrine Carcinoma|Pancreatic Neuroendocrine Tumor|Recurrent Merkel Cell Carcinoma|Recurrent Nasopharynx Carcinoma|Recurrent Peritoneal Malignant Mesothelioma|Recurrent Pleural Malignant Mesothelioma|Stage III Merkel Cell Carcinoma AJCC v7|Stage III Nasopharyngeal Carcinoma AJCC v7|Stage III Pleural Malignant Mesothelioma AJCC v7|Stage IV Merkel Cell Carcinoma AJCC v7|Stage IV Nasopharyngeal Carcinoma AJCC v7|Stage IV Pleural Malignant Mesothelioma AJCC v7|Stage IVA Nasopharyngeal Carcinoma AJCC v7|Stage IVB Nasopharyngeal Carcinoma AJCC v7|Stage IVC Nasopharyngeal Carcinoma AJCC v7|Vaginal Squamous Cell Carcinoma, Not Otherwise Specified | 2017-03-03 | PHASE2 |
| NCT04592029 | Second Affiliated Hospital of Guangzhou Medical University | Hepatocellular Carcinoma Non-resectable | 2020-09-27 | PHASE1 |
| NCT06704724 | Pfizer | Carcinoma, Pancreatic Ductal|Colorectal Neoplasms|Carcinoma, Non-Small-Cell Lung | 2024-12-10 | PHASE1 |
| NCT05579366 | Genmab | High Grade Epithelial Ovarian Cancer|High Grade Serous Ovarian Cancer|Primary Peritoneal Carcinoma|Fallopian Tube Cancer|Endometrial Cancer|Non-small Cell Lung Cancer|Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC)|Mesothelioma|Breast Adenocarcinoma|Triple Negative Breast Cancer|Hormone Receptor-positive+Her2 Negative Breast Cancer|Platinum-resistant Ovarian Cancer (PROC)|Platinum Sensitive Ovarian Cancer (PSOC)|Primary Refractory Ovarian Cancer|Uterine Cancer | 2022-12-07 | PHASE1|PHASE2 |
| NCT07337551 | Guiying Wang | Patients With Metastatic Colorectal Cancer Who Were TP53-mutant and LRPPRC-positive and Had Previously Failed Prior First-line Treatment | 2026-02-01 | PHASE2 |
| NCT00404703 | Hoffmann-La Roche | Non-Small Cell Lung Cancer | 2006-08 | PHASE2 |
| NCT00467142 | Institut Bergonié | Colorectal Cancer | 2007-01-23 | PHASE2 |
| NCT05908786 | Hoffmann-La Roche | Carcinoma, Hepatocellular | 2023-12-05 | PHASE1|PHASE2 |
| NCT07004335 | Hebei Medical University Fourth Hospital|Qilu Pharmaceutical Co., Ltd. | PD-(L)1|CTLA-4|Advanced Melanoma|Iparomlimab|Tuvonralimab|Bevacizumab | 2025-07-01 | PHASE4 |
| NCT01661790 | Chinese PLA General Hospital|Roche Pharma AG | Malignant Pleural Effusion | 2009-08 | PHASE3 |
| NCT02142803 | National Cancer Institute (NCI) | Adult Glioblastoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Malignant Uterine Corpus Neoplasm|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Solid Neoplasm|Stage IIIA Fallopian Tube Cancer AJCC v7|Stage IIIA Ovarian Cancer AJCC v6 and v7|Stage IIIA Primary Peritoneal Cancer AJCC v7|Stage IIIB Fallopian Tube Cancer AJCC v7|Stage IIIB Ovarian Cancer AJCC v6 and v7|Stage IIIB Primary Peritoneal Cancer AJCC v7|Stage IIIC Fallopian Tube Cancer AJCC v7|Stage IIIC Ovarian Cancer AJCC v6 and v7|Stage IIIC Primary Peritoneal Cancer AJCC v7|Stage IV Fallopian Tube Cancer AJCC v6 and v7|Stage IV Ovarian Cancer AJCC v6 and v7|Stage IV Primary Peritoneal Cancer AJCC v7 | 2014-05-20 | PHASE1 |
| NCT07562490 | Fudan University | ctDNA|Chemotherapy|Colorectal Cancer | 2025-04-01 | PHASE2 |
| NCT06023862 | Yonsei University|GlaxoSmithKline | Ovarian Neoplasms|Endometrial Neoplasms|Uterine Cervical Neoplasms|Vulvar Cancer|Vagina Neoplasm|Clear Cell Carcinoma | 2024-01-22 | PHASE2 |
| NCT04601688 | He Eye Hospital | Branch Retinal Vein Occlusion | 2020-10-31 | NA |
| NCT06360042 | Peking University Cancer Hospital & Institute | Unresectable Hepatocellular Carcinoma | 2024-01-01 | PHASE2 |
| NCT05468242 | Sun Yat-sen University | Stage III Non-small Cell Lung Cancer | 2022-01-01 | PHASE2 |
| NCT00632541 | Hoosier Cancer Research Network|Genentech, Inc.|Bayer|Amgen | Metastatic Breast Cancer | 2007-10 | PHASE2 |
| NCT03929666 | Jazz Pharmaceuticals | HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer | 2019-08-29 | PHASE2 |
| NCT04525326 | Fudan University | Colorectal Cancer|Liver Metastases | 2020-10-01 | PHASE3 |
| NCT06031376 | Hunan Cancer Hospital | Metastatic Colorectal Adenocarcinoma | 2019-07-01 | |
| NCT04527068 | Second Affiliated Hospital, School of Medicine, Zhejiang University|Qilu Pharmaceutical Co., Ltd.|Shanghai Junshi Bioscience Co., Ltd. | Refractory Metastatic Colorectal Cancer|pMMR|MSS | 2020-09-20 | PHASE2 |
| NCT06503250 | Hoffmann-La Roche | Unresectable Hepatocellular Carcinoma | 2024-07-19 | |
| NCT00336323 | Jaeb Center for Health Research|National Eye Institute (NEI) | Diabetic Retinopathy | 2006-06 | PHASE2 |
| NCT03353324 | Shahid Beheshti University of Medical Sciences | Retinal Vein Occlusion With Macular Edema | 2017-11-01 | PHASE2|PHASE3 |
| NCT06559488 | Universitas Padjadjaran|Cicendo Eye Hospital | Diabetic Retinopathy|Vitreous Hemorrhage | 2018-04-02 | NA |
| NCT05546879 | University Hospital, Grenoble|NETRIS Pharma | Hepatocellular Carcinoma | 2023-03-15 | PHASE1 |
| NCT00370786 | Shahid Beheshti University of Medical Sciences | Choroidal Neovascularization | 2005-11 | PHASE3 |
| NCT06908031 | Sixth Affiliated Hospital, Sun Yat-sen University | Rectal Adenocarcinoma|High-Risk Cancer|MSS | 2025-04-02 | PHASE2 |
| NCT05231122 | Roswell Park Cancer Institute|Merck Sharp & Dohme LLC|Celldex Therapeutics|United States Department of Defense | Ovarian Clear Cell Adenocarcinoma|Platinum-Sensitive Ovarian Carcinoma|Recurrent Endometrial Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Fallopian Tube Endometrioid Adenocarcinoma|Recurrent Fallopian Tube Serous Adenocarcinoma|Recurrent Ovarian Carcinoma|Recurrent Ovarian Clear Cell Adenocarcinoma|Recurrent Ovarian Endometrioid Adenocarcinoma|Recurrent Ovarian Serous Adenocarcinoma|Recurrent Platinum-Resistant Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Recurrent Primary Peritoneal Clear Cell Adenocarcinoma|Recurrent Primary Peritoneal Endometrioid Adenocarcinoma|Recurrent Primary Peritoneal Serous Adenocarcinoma | 2024-03-12 | PHASE2 |
| NCT02715531 | Hoffmann-La Roche | Solid Tumor | 2016-04-06 | PHASE1 |
| NCT05214339 | Sun Yat-sen University|Third Affiliated Hospital, Sun Yat-Sen University|Nanfang Hospital, Southern Medical University|Xiangya Hospital of Central South University | Unresectable Hepatocellular Carcinoma|Hepatocellular Carcinoma by BCLC Stage | 2022-03-16 | PHASE2 |
| NCT01435395 | Emory University|Schering-Plough|Genentech, Inc.|Millennium Pharmaceuticals, Inc. | Glioblastoma Multiforme | 2011-12 | PHASE1 |
| NCT02354612 | Tracon Pharmaceuticals Inc. | Solid Tumors | | |
| NCT00796757 | Hoffmann-La Roche | Renal Cell Cancer | 2008-12 | PHASE2 |
| NCT07340164 | Yonsei University|Daiichi Sankyo|Boryung Pharmaceutical Co., Ltd | Ovarian Cancer|Ovarian Carcinoma, Recurrent|Ovarian Cancer Metastatic Recurrent|Ovarian Cancer (OvCa) | 2026-02-26 | PHASE2 |
| NCT02394834 | Takeda | Colorectal Cancer | 2015-05-29 | |
| NCT01878422 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Metastatic Colorectal Cancer | 2007-11 | PHASE3 |
| NCT06393751 | National Cancer Institute (NCI) | Platinum-Refractory Fallopian Tube Carcinoma|Platinum-Refractory Ovarian Carcinoma|Platinum-Refractory Primary Peritoneal Carcinoma|Recurrent Fallopian Tube Adenocarcinoma|Recurrent Fallopian Tube Carcinosarcoma|Recurrent Fallopian Tube Clear Cell Adenocarcinoma|Recurrent Fallopian Tube High Grade Serous Adenocarcinoma|Recurrent Fallopian Tube Undifferentiated Carcinoma|Recurrent High Grade Endometrioid Adenocarcinoma|Recurrent Ovarian Adenocarcinoma|Recurrent Ovarian Carcinosarcoma|Recurrent Ovarian Clear Cell Adenocarcinoma|Recurrent Ovarian High Grade Serous Adenocarcinoma|Recurrent Ovarian Seromucinous Carcinoma|Recurrent Ovarian Undifferentiated Carcinoma|Recurrent Platinum-Resistant Fallopian Tube Carcinoma|Recurrent Platinum-Resistant Ovarian Carcinoma|Recurrent Platinum-Resistant Primary Peritoneal Carcinoma|Recurrent Primary Peritoneal Adenocarcinoma|Recurrent Primary Peritoneal Carcinosarcoma|Recurrent Primary Peritoneal Clear Cell Adenocarcinoma|Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma|Recurrent Primary Peritoneal Undifferentiated Carcinoma | 2025-10-31 | PHASE1|PHASE2 |
| NCT07117877 | Fudan University | Platinum Resistant Ovarian Cancer|Platinum Refractory Epithelial Ovarian Cancer|Ovarian Cancer (OvCa) | 2025-09-15 | PHASE2 |
| NCT00436332 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Lung Cancer | 2007-07 | PHASE2 |
| NCT07094893 | Gruppo Oncologico del Nord-Ovest|Merck Serono International SA | Colorectal Cancer | 2026-04-15 | PHASE4 |
| NCT02759614 | Guangdong Association of Clinical Trials | NSCLC | 2016-04-01 | PHASE3 |
| NCT03425292 | Saint John´s Cancer Institute | Newly Diagnosed High Grade Glioma | 2018-03-01 | PHASE1 |
| NCT00674011 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital | Breast Cancer | 2008-01 | |
| NCT01263834 | Prince of Songkla University | Glaucoma | 2010-12 | PHASE2|PHASE3 |
| NCT06791512 | Jun Huang | Colorectal Cancer (CRC)|pMMR+MSS Adenocarcinoma of the Colon or Rectum | 2025-01-18 | PHASE3 |
| NCT00847119 | Institut Català d´Oncologia|Hoffmann-La Roche | Rectal Cancer | 2007-09 | PHASE2 |
| NCT06711471 | LIN YANG | Gastric Cancer Adenocarcinoma Metastatic | 2024-11-14 | PHASE2 |
| NCT00115765 | Amgen | Colorectal Cancer | 2005-06-01 | PHASE3 |
| NCT04425187 | Fudan University | PFS | 2020-06-08 | PHASE2 |
| NCT00217425 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) | Lymphoma | 2006-09-14 | PHASE2 |
| NCT06603376 | Shanghai Changzheng Hospital | Colorectal Carcinoma | 2024-09-01 | PHASE2 |
| NCT00061178 | Genentech, Inc. | Renal Cell Cancer | | PHASE3 |
| NCT00113217 | M.D. Anderson Cancer Center|Genentech, Inc. | Renal Cell Carcinoma|Kidney Cancer | 2005-02 | PHASE2 |
| NCT05109052 | University of Rochester | Hepatocellular Carcinoma|Cancer of Liver | 2022-09-20 | PHASE1|PHASE2 |
| NCT05033106 | Zagazig University|Cairo University | Retinopathy of Prematurity Both Eyes | 2020-09-01 | PHASE3 |
| NCT03169738 | ImmunityBio, Inc. | Non-small Cell Lung Cancer | 2018-02 | PHASE1|PHASE2 |
| NCT00661778 | Hoffmann-La Roche | Non-small Cell Lung Cancer | 2007-07 | PHASE2 |
| NCT01057212 | Providence Health & Services|Genentech, Inc.|Bristol-Myers Squibb | Non-squamous Non-small Cell Lung Cancer | 2010-02 | PHASE2 |
| NCT06873763 | STCube, Inc. | Metastatic Colorectal Cancer (CRC)|Recurrent Colorectal Cancer | 2025-06-09 | PHASE1|PHASE2 |
| NCT00368992 | National Cancer Institute (NCI) | Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer | 2006-08 | PHASE2 |
| NCT00085111 | National Cancer Institute (NCI) | Unspecified Childhood Solid Tumor, Protocol Specific | 2003-12 | PHASE1 |
| NCT00449163 | University of Miami | Colorectal Cancer | 2006-03-01 | PHASE2 |
| NCT00738530 | Hoffmann-La Roche | Renal Cell Cancer | 2004-06 | PHASE3 |
| NCT05044871 | Tongji Hospital|Hubei Cancer Hospital|Union Hospital, Tongji Medical College|Peking University Cancer Hospital & Institute|Anhui Provincial Hospital|Sun Yat-Sen University Cancer Center|Shandong Cancer Hospital and Institute|First Affiliated Hospital Xi´an Jiaotong University|Fujian Cancer Hospital|Chongqing University Cancer Hospital|Qilu Hospital of Shandong University | Ovarian Cancer | 2022-07-22 | PHASE2 |
| NCT05052099 | University Hospital, Essen | Biliary Tract Cancer | 2021-10-22 | PHASE1|PHASE2 |
| NCT00411593 | M.D. Anderson Cancer Center|Millennium Pharmaceuticals, Inc.|Genentech, Inc. | Lung Cancer | 2006-11 | PHASE1|PHASE2 |
| NCT00466687 | Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) | Melanoma | 2004-09 | PHASE2 |
| NCT02010606 | Cedars-Sinai Medical Center | Glioblastoma|Glioblastoma Multiforme|Glioma|Astrocytoma|Brain Tumor | 2014-01-08 | PHASE1 |
| NCT07263438 | Centre Hospitalier Universitaire Vaudois | Glioblastoma|Recurrence Tumor | 2025-11-03 | PHASE2 |
| NCT06838338 | Jian Li | Colorectal Cancer | 2025-03-20 | PHASE1 |
| NCT03063762 | Hoffmann-La Roche | Renal Cell Carcinoma | 2017-03-20 | PHASE1 |
| NCT01437618 | Azienda Ospedaliero, Universitaria Pisana | Metastatic Colorectal Cancer | 2009-06 | |
| NCT00483782 | Medical Research Council | Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer | 2006-04 | PHASE3 |
| NCT06210438 | Fudan University | TNBC|Brain Metastasis | 2024-02-01 | PHASE2 |
| NCT00975897 | Medical Research Council | Colorectal Cancer | 2009-07 | PHASE2|PHASE3 |
| NCT01821859 | OHSU Knight Cancer Institute | Ovarian Cancer|Peritoneal Cancer | 2010-01 | PHASE2 |
| NCT00600821 | Pfizer | Non-Small-Cell Lung Carcinoma|Adenocarcinoma | 2008-04 | PHASE2 |
| NCT00898417 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI) | Lung Cancer | 2008-03-14 | |
| NCT03376659 | Georgetown University|Mayo Clinic|Indiana University|Emory University|National Cancer Institute (NCI)|George Mason University|Thomas Jefferson University|MedImmune LLC|Bavarian Nordic | Metastatic Colorectal Cancer|Colorectal Adenocarcinoma|Pancreatic Adenocarcinoma|Metastatic Pancreatic Cancer | 2018-08-08 | PHASE1|PHASE2 |
| NCT00343291 | Eli Lilly and Company | Non-Small Cell Lung Cancer | 2006-12 | PHASE2 |
| NCT02210117 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Clear Cell Renal Cell Carcinoma|Metastatic Kidney Carcinoma|Stage IV Renal Cell Cancer AJCC v7 | 2014-11-25 | EARLY_PHASE1 |
| NCT00892710 | SCRI Development Innovations, LLC|Genentech, Inc. | Non Small Cell Lung Cancer | 2009-06 | PHASE2 |
| NCT00434226 | Genentech, Inc. | Non-Small Cell Lung Cancer | 2007-03 | PHASE2 |
| NCT04626635 | Regeneron Pharmaceuticals | Advanced Solid Tumors | 2020-12-21 | PHASE1|PHASE2 |
| NCT05009082 | AGO Study Group|European Network of Gynaecological Oncological Trial Groups (ENGOT) | Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer | 2022-09-13 | PHASE3 |
| NCT05906524 | Shanghai Kanda Biotechnology Co., Ltd. | Advanced HCC|Other Solid Tumors | 2024-04-15 | PHASE1|PHASE2 |
| NCT00533585 | M.D. Anderson Cancer Center|Bayer | Lung Cancer | 2006-05 | PHASE1 |
| NCT01967810 | Angiochem Inc | Glioma|Glioblastoma|Brain Tumor, Recurrent | 2013-10 | PHASE2 |
| NCT00675259 | Ohio State University Comprehensive Cancer Center|Celgene Corporation|Genentech, Inc. | Breast Cancer | 2008-07 | PHASE2 |
| NCT07239596 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Advanced Renal Cell Carcinoma | 2026-01-06 | PHASE1|PHASE2 |
| NCT00255762 | National Cancer Institute (NCI) | Recurrent Melanoma|Stage IV Melanoma | 2005-12 | PHASE2 |
| NCT04991350 | Cairo University | Diabetic Macular Edema|Macular Ischemia|Diabetic Retinopathy|Vascular Endothelial Growth Factor Overexpression | 2021-11-26 | PHASE4 |
| NCT00988897 | Sanofi | Colorectal Neoplasms | 2009-10 | PHASE2 |
| NCT03940690 | Fondation Ophtalmologique Adolphe de Rothschild | Retinal Telangiectasis|Coats Disease | 2019-10-24 | PHASE3 |
| NCT00628810 | Federation Francophone de Cancerologie Digestive | Colorectal Cancer | 2007-01 | PHASE2 |
| NCT03434379 | Hoffmann-La Roche | Carcinoma, Hepatocellular | 2018-03-15 | PHASE3 |
| NCT03220932 | Hospices Civils de Lyon | Ovarian Epithelial Cancer | 2019-11-30 | PHASE3 |
| NCT05065021 | University Health Network, Toronto|GlaxoSmithKline | Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer|High Grade Serous Cancer|High Grade Endometrioid Cancer | 2023-02-23 | PHASE2 |
| NCT06725121 | University Health Network, Toronto | Hepatocellular Carcinoma (HCC)|Macrovascular Invasion|Liver Transplant Surgery|Downstaging | 2024-12 | PHASE1|PHASE2 |
| NCT00390416 | Memorial Sloan Kettering Cancer Center|Sanofi|Genentech, Inc. | Stomach Neoplasms|Esophageal Neoplasms | 2006-10 | PHASE2 |
| NCT00660621 | Kentuckiana Cancer Institute|Eisai Inc. | Glioma | 2008-04 | PHASE2 |
| NCT06954584 | Tongji Hospital | Ovarian Cancer | 2025-05-27 | PHASE3 |
| NCT04689347 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Metastatic Colorectal Cancer | 2021-01-01 | PHASE1|PHASE2 |
| NCT01164189 | European Organisation for Research and Treatment of Cancer - EORTC|Hoffmann-La Roche | Central Nervous System Tumors | 2011-02 | PHASE2 |
| NCT04988191 | Peking University | Colorectal Carcinoma | 2020-12-24 | PHASE1|PHASE2 |
| NCT03990103 | China Medical University, China | Metastatic Gastric Adenocarcinoma | 2017-11-01 | PHASE2 |
| NCT03693573 | Hoffmann-La Roche | Renal Cell Carcinoma | 2019-01-11 | PHASE3 |
| NCT06363552 | Tianshu Liu | Metastatic Colorectal Cancer | 2024-05 | PHASE2 |
| NCT06958484 | The Affiliated Hospital of Xuzhou Medical University | HCC - Hepatocellular Carcinoma|Adjuvant Treatment | 2025-05-01 | PHASE2 |
| NCT00434252 | Genentech, Inc. | Melanoma | 2007-02 | PHASE2 |
| NCT00541125 | Federation Francophone de Cancerologie Digestive | Colorectal Cancer | 2007-11 | PHASE2 |
| NCT05799820 | Qilu Pharmaceutical Co., Ltd. | Colorectal Carcinoma | 2022-09-29 | PHASE2 |
| NCT06177288 | Fudan University | Colorectal Neoplasms | 2024-01-01 | NA |
| NCT00496405 | Asociación para Evitar la Ceguera en México | Diabetic Macular Edema|Diabetic Retinopathy | 2007-04 | PHASE4 |
| NCT01609790 | National Cancer Institute (NCI)|NRG Oncology | Giant Cell Glioblastoma|Glioblastoma|Gliosarcoma|Oligodendroglioma|Recurrent Brain Neoplasm|Recurrent Glioblastoma | 2012-06-04 | PHASE2 |
| NCT00370422 | Shahid Beheshti University of Medical Sciences | Diabetic Macular Edema | 2005-11 | PHASE3 |
| NCT03024437 | Roberto Pili|Genentech, Inc.|Syndax Pharmaceuticals | Metastatic Cancer|Renal Cancer | 2017-06-29 | PHASE1|PHASE2 |
| NCT00709657 | Medical University of Vienna | Macular Degeneration|Regional Blood Flow|Vascular Endothelial Growth Factor | 2008-03 | NA |
| NCT07075757 | Assistance Publique - H?pitaux de Paris | Brain Arteriovenous Malformations | 2025-10-01 | PHASE1 |
| NCT03095001 | Chinese PLA General Hospital | Peritoneal Adhesion | 2017-06-01 | PHASE2 |
| NCT00800202 | Hoffmann-La Roche | Non-Small Cell Lung Cancer | 2009-04 | PHASE2 |
| NCT01217437 | National Cancer Institute (NCI) | Central Nervous System Neoplasm|Pineoblastoma|Recurrent Medulloblastoma|Recurrent Primitive Neuroectodermal Tumor|Refractory Medulloblastoma|Refractory Peripheral Primitive Neuroectodermal Tumor | 2010-11-22 | PHASE2 |
| NCT03167177 | ImmunityBio, Inc. | Melanoma | 2017-12 | PHASE1|PHASE2 |
| NCT02663271 | University of Florida|NovoCure Ltd. | Glioblastoma Multiforme|Glioblastoma|Malignant Glioma|GBM | 2016-12-19 | PHASE2 |
| NCT05410301 | Varun Monga, MD|University of Iowa | Glioblastoma|Recurrent Glioblastoma | 2023-04 | NA |
| NCT07351487 | First Affiliated Hospital of Zhejiang University | TNBC - Triple-Negative Breast Cancer | 2025-09-25 | PHASE2 |
| NCT00423930 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Genentech, Inc. | Head and Neck Cancer | 2006-10 | PHASE2 |
| NCT05883176 | Sun Yat-sen University | Hepatocellular Carcinoma by BCLC Stage | 2023-06-01 | PHASE2 |
| NCT04034459 | Ludwig-Maximilians - University of Munich | Metastatic Colorectal Cancer | 2016-11-25 | PHASE2 |
| NCT01254526 | Genentech, Inc. | Breast Cancer | 2010-12 | PHASE1 |
| NCT01531595 | Pia Osterlund | Metastatic Colorectal Cancer | 2012-02 | PHASE2 |
| NCT01917877 | Qingdao Central Hospital | Pulmonary Fibrosis | 2013-08-01 | PHASE2 |
| NCT01364012 | Hoffmann-La Roche | Non-Small Cell Lung Cancer | 2011-05-23 | PHASE3 |
| NCT00976456 | PD Dr. med. Wolfgang Schuette|Roche Pharma AG|Eli Lilly and Company | Non-squamous Non-small Cell Lung Cancer | 2009-09 | PHASE3 |
| NCT02612077 | Hoffmann-La Roche | Metastatic Colorectal Cancer | 2008-05 | |
| NCT05717400 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Liver Cancer | 2023-03-17 | PHASE4 |
| NCT00842686 | Institute of Oncology Ljubljana | Locally Advanced Rectal Cancer | 2009-01 | PHASE2 |
| NCT05185505 | The Methodist Hospital Research Institute|Genentech, Inc. | Hepatocellular Carcinoma|Hepatocellular Cancer | 2023-01-30 | PHASE4 |
| NCT00434356 | Genentech, Inc. | Metastatic Breast Cancer | 2007-03 | PHASE2 |
| NCT06415851 | Zhangfa Song | Metastatic Colorectal Cancer|MSS | 2024-06-01 | PHASE2 |
| NCT06039202 | Holy Stone Healthcare Co., Ltd | Metastatic Colorectal Cancer | 2024-01 | PHASE2 |
| NCT03181100 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Metastatic Thyroid Gland Carcinoma|Poorly Differentiated Thyroid Gland Carcinoma|Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8|Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8|Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8|Thyroid Gland Anaplastic Carcinoma|Unresectable Thyroid Gland Carcinoma | 2017-07-27 | PHASE2 |
| NCT03126071 | Jiangsu Cancer Institute & Hospital | Advanced Colorectal Cancer | 2017-02-15 | PHASE2 |
| NCT01837251 | AGO Research GmbH|Arbeitsgemeinschaft Gynaekologische Onkologie Austria|ARCAGY+ GINECO GROUP|Australia New Zealand Gynaecological Oncology Group|Scottish Gynaecological Cancer Study Group | Recurrent Platinum-sensitive Ovarian Cancer | 2013-05 | PHASE3 |
| NCT07119931 | Tianjin Medical University Cancer Institute and Hospital | HCC | 2025-09-10 | PHASE2 |
| NCT03843853 | The First Affiliated Hospital with Nanjing Medical University|Jiangsu HanSoh Tharmaceutical Group Co., Ltd | Colorectal Neoplasms | 2019-05-01 | PHASE2 |
| NCT00588237 | Memorial Sloan Kettering Cancer Center|Genentech, Inc. | Ovarian Cancer|Primary PERITONEUM|Fallopian Tube Cancer | 2006-08 | PHASE2 |
| NCT05886257 | Shi Ming | Hepatocellular Carcinoma | 2022-12-07 | PHASE2 |
| NCT01871571 | University of Southern California|National Cancer Institute (NCI) | Mucinous Adenocarcinoma of the Rectum|Signet Ring Adenocarcinoma of the Rectum|Stage IIA Rectal Cancer|Stage IIB Rectal Cancer|Stage IIC Rectal Cancer|Stage IIIA Rectal Cancer|Stage IIIB Rectal Cancer|Stage IIIC Rectal Cancer | 2013-08-02 | PHASE2 |
| NCT04215731 | Yanhong Deng | Rectal Cancer | 2020-03-27 | PHASE3 |
| NCT03597581 | Inspirna, Inc. | Gastrointestinal Cancer|Gastrointestinal Neoplasms|Colorectal Cancer|Colorectal Neoplasms|Colorectal Carcinoma|Gastric Cancer|Gastric Neoplasm|KRAS Mutation-Related Tumors|CRC|Colorectal Cancer Metastatic | 2018-06-05 | PHASE1 |
| NCT01832415 | ARCAGY+ GINECO GROUP|Roche Pharma AG | Epithelial Ovarian Cancer | 2013-04 | |
| NCT02007174 | Instituto de Oftalmología Fundación Conde de Valenciana|National Council of Science and Technology, Mexico | Recurrent Pterygium | 2012-03 | |
| NCT00670982 | Harold J. Burstein, MD, PhD|Brigham and Women´s Hospital|Beth Israel Deaconess Medical Center|Massachusetts General Hospital|Genentech, Inc.|New Hampshire Oncology-Hematology PA|Lowell General Hospital|Hartford Hospital | Breast Cancer | 2008-05 | PHASE2 |
| NCT05718466 | Henry Ford Health System | Recurrent or Progressive Glioblastoma | 2010-11 | PHASE3 |
| NCT02015351 | University of Sao Paulo|Funda??o de Amparo à Pesquisa do Estado de S?o Paulo | Choroidal Neovascularization | 2012-09 | NA |
| NCT00511459 | Amgen | Locally Recurrent and Metastatic Breast Cancer | 2007-07 | PHASE2 |
| NCT00684996 | National Cancer Institute (NCI) | Recurrent Renal Cell Cancer|Renal Cell Carcinoma|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer | 2008-06 | PHASE1|PHASE2 |
| NCT01072357 | Reza Dana, MD | Corneal Neovascularization|Corneal Graft Failure | 2009-12 | PHASE1|PHASE2 |
| NCT00578149 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital | Non-Small Cell Lung Cancer | 2006-05 | PHASE2 |
| NCT04121455 | TME Pharma AG | Glioblastoma | 2019-09-12 | PHASE1|PHASE2 |
| NCT04516447 | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | Solid Tumor|Epithelial Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer | 2020-10-26 | PHASE1 |
| NCT00137826 | Dana-Farber Cancer Institute|Massachusetts General Hospital|University of Chicago | Mesothelioma | 2004-02 | PHASE2 |
| NCT02659384 | European Organisation for Research and Treatment of Cancer - EORTC | Ovarian Neoplasms | 2016-12-23 | PHASE2 |
| NCT00356031 | Massachusetts General Hospital|National Institutes of Health (NIH)|National Cancer Institute (NCI) | Soft Tissue Sarcoma|Fibrous Histiocytoma|Liposarcoma|Leiomyosarcoma|Fibrosarcoma|Synovial Sarcoma | 2006-07 | PHASE2 |
| NCT01113476 | M.D. Anderson Cancer Center | Advanced Cancer | 2010-04-27 | PHASE1 |
| NCT03115762 | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | Healthy | 2017-06 | PHASE1 |
| NCT00393861 | Indiana University|Genentech, Inc. | Neoplasms, Germ Cell and Embryonal | 2006-10 | PHASE2 |
| NCT00069095 | Hoffmann-La Roche | Colorectal Cancer | 2003-07 | PHASE3 |
| NCT03690739 | AGO Research GmbH | Recurrent Ovarian Carcinoma | 2019-08-09 | PHASE3 |
| NCT06121401 | Mario Negri Institute for Pharmacological Research|AstraZeneca | Carcinoma, Ovarian Epithelial | 2023-09-15 | PHASE4 |
| NCT00349336 | Hoffmann-La Roche | Colorectal Cancer | 2006-08 | PHASE3 |
| NCT01332721 | Tracon Pharmaceuticals Inc. | Adult Solid Tumor | 2011-04 | PHASE1 |
| NCT05330065 | The First Affiliated Hospital of Zhengzhou University | Malignant Pleural Effusion | 2022-08-01 | PHASE1|PHASE2 |
| NCT04553692 | IGM Biosciences, Inc. | Solid Tumor|Colorectal Cancer|Non Hodgkin Lymphoma|Sarcoma|Chondrosarcoma|Small Lymphocytic Lymphoma|Chronic Lymphocytic Leukemia|Acute Myeloid Leukemia | 2020-09-23 | PHASE1 |
| NCT02195336 | Karl K?lbeck | Non-small Cell Lung Cancer | 2014-08 | NA |
| NCT01614509 | Yeungnam University College of Medicine | Branch Retinal Vein Occlusion | 2012-01 | NA |
| NCT00883298 | Center for Neurosciences, Tucson|Genentech, Inc. | Recurrent Glioblastoma Multiforme|Recurrent Gliosarcoma | 2009-04 | PHASE2 |
| NCT04067856 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Allergan|Doheny Image Reading Center | Diabetic Macular Edema|Cataract | 2020-01-01 | NA |
| NCT00373256 | Pfizer | Breast Neoplasms | 2006-11 | PHASE3 |
| NCT06882551 | Khyber Teaching Hospital | Diabetic Macular Edema (DME) | 2023-04-01 | PHASE4 |
| NCT01763671 | Intergroupe Francophone de Cancerologie Thoracique | Non-squamous Non-small Cell Lung Cancer | 2013-05 | PHASE3 |
| NCT05378867 | Zhejiang Teruisi Pharmaceutical Inc. | Metastatic Colorectal Cancer (CRC) | 2022-08-01 | PHASE3 |
| NCT00532909 | Branimir Sikic|AstraZeneca | Anal, Colon, and Rectal Cancers|Colorectal Neoplasms|Colon+Rectal Cancer | 2006-07 | PHASE1 |
| NCT00089609 | National Cancer Institute (NCI) | Prostatic Neoplasms | 2005-04-19 | PHASE2 |
| NCT06003998 | Catharina Ziekenhuis Eindhoven | Colorectal Cancer|Peritoneal Metastases | 2022-12-27 | PHASE2 |
| NCT01588704 | Si-Yu Wang | Lung Cancer | 2012-04 | PHASE2 |
| NCT00370539 | Shahid Beheshti University of Medical Sciences | Neovascular Age-Related Macular Degeneration | 2006-09 | PHASE3 |
| NCT00484939 | Hoffmann-La Roche | Colorectal Cancer | 2007-07 | PHASE3 |
| NCT00193219 | SCRI Development Innovations, LLC|Bristol-Myers Squibb | Colon Cancer | 2005-07 | PHASE2 |
| NCT00970970 | University Medical Center Groningen|VHL Alliance | Von Hippel-Lindau Disease|Hemangioblastoma|Renal Cell Carcinoma|Pheochromocytoma|Pancreatic Neuroendocrine Tumor | 2009-09 | |
| NCT05363722 | Shanghai Zhongshan Hospital | Hepatocellular Carcinoma | 2022-05 | PHASE1 |
| NCT00193375 | SCRI Development Innovations, LLC|Genentech, Inc.|Pharmacia and Upjohn | Lung Cancer | 2003-08 | PHASE2 |
| NCT01311050 | King Faisal Specialist Hospital & Research Center | Metastatic Colorectal Cancer | 2009-01 | |
| NCT01386710 | Northwell Health | Glioblastoma Multiforme|Anaplastic Astrocytoma | 2011-09 | PHASE1|PHASE2 |
| NCT01256580 | Massachusetts Eye and Ear Infirmary | Choroidal Neovascularization|Myopia|Punctate Inner Choroidopathy (PIC)|Multifocal Choroiditis|Ocular Histoplasmosis Syndrome|Central Serous Chorioretinopathy (CSC)|Angioid Streaks|Trauma, or Hereditary Eye Diseases | 2010-08 | NA |
| NCT07543783 | Third Affiliated Hospital, Sun Yat-Sen University|Shanghai Shengdi Pharmaceutical Co., Ltd | Adebrelimab (SHR-1316)|Bevacizumab|Hepatocellular Carcinoma (HCC) | 2026-04-10 | PHASE2 |
| NCT00809133 | Boehringer Ingelheim | Neoplasms | 2007-05 | PHASE1 |
| NCT07284849 | Incyte Corporation | CRC (Colorectal Cancer) | 2026-03-05 | PHASE3 |
| NCT00925652 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Beth Israel Deaconess Medical Center|Translational Breast Cancer Research Consortium|Genentech, Inc. | Breast Cancer | 2010-09 | PHASE2 |
| NCT00756340 | St. Jude Children´s Research Hospital|Novartis Pharmaceuticals | Recurrent or Refractory Solid Tumors|CNS Malignancies | 2008-07 | PHASE1 |
| NCT00667342 | St. Jude Children´s Research Hospital|Genentech, Inc. | Osteosarcoma|Malignant Fibrous Histiocytoma (MFH) of Bone | 2008-06-03 | PHASE2 |
| NCT00095459 | National Cancer Institute (NCI) | Neoplasms | 2004-11-02 | PHASE1 |
| NCT07005570 | Dechang Diao | pMMR+MSS Locally Advanced Rectal Cancer | 2025-05-01 | PHASE2 |
| NCT04861948 | Innovent Biologics (Suzhou) Co. Ltd. | Solid Tumors|Lung Adenocarcinoma|Osteosarcoma | 2021-05-25 | PHASE1 |
| NCT00710268 | AstraZeneca | Neoplasm Metastasis | 2008-06 | PHASE1 |
| NCT06843954 | Mohammed Mahmood Mohammed | Colo-rectal Cancer | 2022-09-01 | PHASE4 |
| NCT00681603 | National Taiwan University Hospital | Lipid Keratopathy|Penetrating Keratoplasty|Herpetic Keratopathy|Rosacea | 2007-08 | NA |
| NCT00464646 | NSABP Foundation Inc|Genentech, Inc.|International Drug Development Institute | Breast Cancer | 2007-05 | PHASE2 |
| NCT00976573 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Melanoma (Skin) | 2010-04 | PHASE2 |
| NCT00612430 | Duke University|Genentech, Inc. | Glioblastoma|Gliosarcoma | 2007-03 | PHASE2 |
| NCT00887536 | NSABP Foundation Inc|Genentech, Inc.|US Oncology Research | Breast Cancer | 2009-05 | PHASE3 |
| NCT03396926 | University of California, San Francisco|Merck Sharp & Dohme LLC | Microsatellite Stable|Mismatch Repair Protein Proficient|Stage III Colorectal Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IV Colorectal Cancer AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7 | 2018-04-18 | PHASE2 |
| NCT02072720 | Amsterdam UMC, location VUmc|Noordwest Ziekenhuisgroep|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Primary Esophageal Carcinoma | 2014-02 | EARLY_PHASE1 |
| NCT05617430 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Hepatocellular Carcinoma | 2022-11-02 | PHASE2 |
| NCT07054567 | Sichuan Baili Pharmaceutical Co., Ltd.|Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. | Cervical Cancer|Endometrial Cancer | 2025-08-21 | PHASE2 |
| NCT02620800 | Celgene | Metastatic Pancreas Adenocarcinoma | 2016-01-18 | PHASE1 |
| NCT06701656 | PPD Development, LP|Biomedical Advanced Research and Development Authority|InflaRx GmbH|Edesa Biotech Inc.|Genentech, Inc. | Acute Respiratory Distress Syndrome (ARDS)|ARDS|ARDS (Acute Respiratory Distress Syndrome)|Acute Respiratory Distress Syndrome | 2025-10-28 | PHASE2 |
| NCT01405430 | Centre Leon Berard|UMR-S Inserm 1036 | Colorectal Cancer|Metastasis | 2010-05 | NA |
| NCT04595266 | Grupo Espanol Multidisciplinario del Cancer Digestivo | Colorectal Cancer Metastatic|Liver Metastasis Colon Cancer | 2021-06-29 | PHASE2 |
| NCT00602329 | Abramson Cancer Center at Penn Medicine|National Cancer Institute (NCI) | Colorectal Cancer | 2006-02 | PHASE2 |
| NCT00879437 | Baylor College of Medicine|Cook Children´s Medical Center|University of Oklahoma|University of Texas, Southwestern Medical Center at Dallas|The University of Texas Health Science Center at San Antonio|M.D. Anderson Cancer Center | Glial Cell Tumors|Malignant Gliomas|Glioblastoma Multiforme|Anaplastic Astrocytoma|Gliomatosis Cerebri|Gliosarcoma|Brainstem Glioma|Diffuse Intrinsic Pontine Glioma | 2009-09-01 | PHASE2 |
| NCT06899529 | Christian Ophthalmic Surgery Expedition Network | Proliferative Diabetic Retinopathy - High Risk | 2025-03-20 | NA |
| NCT07549412 | EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany | Metastatic Colorectal Cancer | 2026-05-06 | PHASE3 |
| NCT06540261 | Ono Pharmaceutical Co., Ltd. | Unresectable Colorectal Cancer | 2021-09-23 | PHASE1 |
| NCT00120172 | Geriatric Oncology Consortium|Sanofi | Colorectal Cancer|Neoplasm Metastasis | 2005-05 | PHASE2 |
| NCT01767545 | Ludwig-Maximilians - University of Munich | Macular Edema Caused by Retinal Vein Occlusion | 2010-09 | PHASE4 |
| NCT06109272 | AbbVie | Hepatocellular Carcinoma | 2024-01-11 | PHASE2|PHASE3 |
| NCT01217931 | M.D. Anderson Cancer Center|Novartis | Kidney Cancer | 2011-01-19 | PHASE2 |
| NCT01705002 | Lipomedix Pharmaceuticals Inc. | Cancer|Solid Tumor|Metastatic Colorectal Cancer (mCRC) | 2012-10 | PHASE1 |
| NCT06550453 | yangjianjun | Locally Advanced Colorectal Cancer | 2024-09-01 | PHASE4 |
| NCT02174172 | Hoffmann-La Roche | Solid Cancers | 2014-08-18 | PHASE1 |
| NCT00773695 | Hoffmann-La Roche|Norwegian Radium Hospital | Breast Cancer | 2008-11-07 | PHASE2 |
| NCT00806169 | Johann Wolfgang Goethe University Hospital | Macular Edema|Diabetic Retinopathy | 2006-04 | PHASE3 |
| NCT03382886 | University of Utah|Bristol-Myers Squibb | Hepatocellular Carcinoma | 2018-04-11 | PHASE1 |
| NCT01580969 | University of Utah | Recurrent Glioma | 2012-07-06 | PHASE1|PHASE2 |
| NCT00106054 | Pfizer | Colorectal Neoplasms|Liver Neoplasms | 2006-01 | PHASE2 |
| NCT04931342 | Hoffmann-La Roche|GOG Foundation|European Network of Gynaecological Oncological Trial Groups (ENGOT) | Ovarian Cancer | 2021-10-07 | PHASE2 |
| NCT01471054 | Arman Mashayekhi|Allergan | Macular Edema|Cystoid Macular Edema|Uveal Melanoma|Radiation Maculopathy|Radiation Retinopathy | 2014-04 | PHASE2 |
| NCT00516295 | National Cancer Institute (NCI) | Ewing Sarcoma of Bone|Extraosseous Ewing Sarcoma|Peripheral Primitive Neuroectodermal Tumor|Recurrent Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor | 2008-02 | PHASE2 |
| NCT02930954 | Caicun Zhou | Non-small-cell Lung Cancer | 2016-11 | PHASE2 |
| NCT02606305 | ImmunoGen, Inc. | Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer | 2016-03-02 | PHASE1|PHASE2 |
| NCT00710229 | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery|Krankenanstalt Rudolfstiftung|Medical University of Vienna|Medical University of Graz|Medical University Innsbruck|Krankenhaus der Barmherzigen Brüder Linz|Universit?tsaugenklinik Salzburg|Hospital Hietzing|Hanuschkrankenhaus | Age Related Macular Degeneration | 2008-07 | PHASE3 |
| NCT02695641 | Mayo Clinic | End Stage Renal Disease|Hemodialysis Vascular Access Failure | 2019-08-01 | EARLY_PHASE1 |
| NCT04601701 | He Eye Hospital | Central Retinal Vein Occlusion | 2020-10-17 | NA |
| NCT06808412 | xiaohua li | Rcctal Cancer | 2024-07-05 | PHASE2 |
| NCT04829383 | Howard S Hochster|Genentech, Inc.|Rutgers Cancer Institute of New Jersey | Unresectable Hepatocellular Carcinoma | 2021-03-22 | PHASE2 |
| NCT00468429 | Grewal Eye Institute | Glaucoma | 2007-05 | PHASE4 |
| NCT00967330 | Hoffmann-La Roche | Glioblastoma Multiforme | 2010-06 | PHASE2 |
| NCT00795665 | University of California, Davis|National Cancer Institute (NCI)|Genentech, Inc. | Glioma | 2008-06 | PHASE2 |
| NCT00887822 | Hoffmann-La Roche | Gastric Cancer | 2009-03 | PHASE3 |
| NCT06827353 | Centre Hospitalier Universitaire de N?mes | Ovarian Carcinoma | 2020-10-01 | |
| NCT06280495 | Sun Yat-sen University | Colorectal Cancer|Liver Metastases | 2024-02-01 | PHASE2|PHASE3 |
| NCT00884741 | National Cancer Institute (NCI)|Radiation Therapy Oncology Group|NRG Oncology | Glioblastoma|Gliosarcoma|Supratentorial Glioblastoma | 2009-04-15 | PHASE3 |
| NCT00140556 | David M. Brizel, MD|Genentech, Inc.|OSI Pharmaceuticals | Head and Neck Cancer|Pharynx Cancer | 2005-08 | EARLY_PHASE1 |
| NCT06225622 | Shanghai Zhongshan Hospital|CSPC Ouyi Pharmaceutical Co., Ltd. | Metastatic Colorectal Cancer | 2024-03-11 | PHASE1 |
| NCT07025239 | Qilu Pharmaceutical Co., Ltd. | Metastatic Colorectal Cancer | 2025-07 | PHASE3 |
| NCT07503756 | Shanghai Junshi Bioscience Co., Ltd. | Metastatic Colorectal Cancer | 2026-04-25 | PHASE2 |
| NCT05638451 | Zhujiang Hospital | Recurrent Glioblastoma | 2023-05-01 | PHASE2 |
| NCT04147351 | National Taiwan University Hospital | NSCLC Stage IIIB~IV | 2020-04-10 | PHASE2 |
| NCT01946529 | St. Jude Children´s Research Hospital|University of Tennessee|University of Florida|Nemours Children´s Clinic | Desmoplastic Small Round Cell Tumor|Ewing Sarcoma of Bone or Soft Tissue|Localized Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor|Metastatic Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor | 2013-12-27 | PHASE2 |
| NCT00268359 | Duke University|National Cancer Institute (NCI) | Brain and Central Nervous System Tumors | 2005-05 | PHASE2 |
| NCT01402531 | University of California, San Diego | Hereditary Hemorrhagic Telangiectasia (HHT) | 2010-07-22 | PHASE2 |
| NCT03635021 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|Amgen | Colorectal Cancer | 2018-10-15 | PHASE3 |
| NCT04421378 | Karyopharm Therapeutics Inc | Glioblastoma Multiforme | 2020-06-08 | PHASE1|PHASE2 |
| NCT06492408 | Second Affiliated Hospital of Guangzhou Medical University | Hepatic Cancer|Surgery | 2024-07-01 | PHASE2 |
| NCT00252564 | US Oncology Research|Bristol-Myers Squibb|Memorial Sloan Kettering Cancer Center|Prologue Research International | Metastatic Colorectal Cancer | 2005-09 | PHASE3 |
| NCT06530784 | Shanghai Zhongshan Hospital | Carcinoma, Hepatocellular | 2024-07-31 | PHASE2 |
| NCT00417833 | Asociación para Evitar la Ceguera en México | Diabetic Proliferative Retinopathy|Vascular Vein Oclussion|Choroidal Neovascularization | 2005-12 | PHASE2|PHASE3 |
| NCT05739981 | Imunon|Breakthrough Cancer Research | Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer | 2023-02-10 | PHASE1|PHASE2 |
| NCT07007767 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Colorectal Cancer Metastatic | 2025-06-15 | PHASE2 |
| NCT01159236 | M.D. Anderson Cancer Center | Breast Cancer | 2010-09 | NA |
| NCT00084604 | National Cancer Institute (NCI) | Adenocarcinoma of the Gastroesophageal Junction|Diffuse Adenocarcinoma of the Stomach|Intestinal Adenocarcinoma of the Stomach|Mixed Adenocarcinoma of the Stomach|Recurrent Gastric Cancer|Stage IIIA Gastric Cancer|Stage IIIB Gastric Cancer|Stage IIIC Gastric Cancer|Stage IV Gastric Cancer | 2004-04 | PHASE2 |
| NCT03038100 | Hoffmann-La Roche|GOG Foundation|European Network of Gynaecological Oncological Trial Groups (ENGOT) | Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Neoplasms | 2017-03-08 | PHASE3 |
| NCT07228832 | Summit Therapeutics | Metastatic Colorectal Cancer (CRC) | 2025-11-18 | PHASE3 |
| NCT02988843 | Masonic Cancer Center, University of Minnesota | Germ Cell Tumor | 2017-03-29 | PHASE2 |
| NCT00974389 | Osaka Medical College | Colorectal Cancer | 2009-07 | PHASE2 |
| NCT03587311 | National Cancer Institute (NCI) | Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube High Grade Serous Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian High Grade Serous Adenocarcinoma|Platinum-Resistant Fallopian Tube Carcinoma|Platinum-Resistant Ovarian Carcinoma|Platinum-Resistant Primary Peritoneal Carcinoma|Primary Peritoneal High Grade Serous Adenocarcinoma | 2018-10-12 | PHASE2 |
| NCT00326911 | Eli Lilly and Company | Metastatic Pancreatic Cancer | 2006-05 | PHASE2 |
| NCT00548197 | Iran University of Medical Sciences | Intravitreal Bevacizumab Injection|Pars Plana Vitrectomy|Tractional Retinal Detachment|Diabetic Retinopathy | 2007-02 | PHASE1 |
| NCT00961415 | Hoffmann-La Roche | Non-Squamous Non-Small Cell Lung Cancer | 2009-08 | PHASE3 |
| NCT05992220 | Asan Medical Center|Seoul National University Hospital|Hanyang University Guri Hospital|Soon Chun Hyang University | Hepatocellular Carcinoma|Hepatocellular Cancer|Hepatocellular Carcinoma Non-resectable|Hepatocellular Carcinoma Stage IV|Liver Cancer | 2022-10-22 | PHASE2 |
| NCT00345696 | Unidad Integral de Investigación en Oncología S.L.|Hoffmann-La Roche | Metastatic Colorectal Cancer | 2006-06 | PHASE2 |
| NCT04175158 | Genor Biopharma Co., Ltd. | Non-small Cell Lung Cancer | 2017-04-24 | PHASE1 |
| NCT07021950 | Sun Yat-sen University | Colorectal Cancer|Ivonescimab | 2025-08-10 | PHASE2 |
| NCT07002346 | Tongji Hospital|Chinese Academy of Medical Sciences|Peking Union Medical College Hospital|Fudan University|Sun Yat-Sen University Cancer Center|Peking University Cancer Hospital & Institute|Peking University People´s Hospital|First Affiliated Hospital, Sun Yat-Sen University|The Second Affiliated Hospital, Sun Yat-sen University|Second Affiliated Hospital, School of Medicine, Zhejiang University|Renmin Hospital of Wuhan University|Zhejiang Provincial People´s Hospital|Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center|Shanghai First Maternity and Infant Hospital|Hubei Cancer Hospital|Sir Run Run Shaw Hospital|Wuhan Central Hospital|Zhejiang Cancer Hospital|The First Affiliated Hospital of Zhengzhou University|Third Affiliated Hospital of Zhengzhou University|Henan Provincial People´s Hospital|Henan Cancer Hospital|Jiangsu Cancer Institute & Hospital|The International Peace Maternity & Child Health Hospital of China welfare institute|Women´s Hospital School Of Medicine Zhejiang University|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology|First Affiliated Hospital of Zhejiang University | Ovarian Clear Cell Carcinoma | 2025-06-01 | PHASE3 |
| NCT00052559 | National Cancer Institute (NCI) | Adenocarcinoma of the Rectum|Stage II Rectal Cancer|Stage III Rectal Cancer | 2002-08 | PHASE1 |
| NCT06040099 | AstraZeneca | Hepatocellular Carcinoma (HCC) | 2024-02-13 | PHASE2 |
| NCT00762255 | H. Lee Moffitt Cancer Center and Research Institute|Merck Sharp & Dohme LLC | Glioblastoma | 2008-09 | PHASE1 |
| NCT03792074 | Sinocelltech Ltd. | Non-squamous Cell Non-small Cell Lung Cancer | 2019-02 | PHASE3 |
| NCT06887218 | The Methodist Hospital Research Institute | Metastatic Colorectal Cancer (CRC) | 2025-05-08 | PHASE2 |
| NCT00381797 | National Cancer Institute (NCI) | Childhood Cerebral Anaplastic Astrocytoma|Childhood Oligodendroglioma|Childhood Spinal Cord Neoplasm|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Ependymoma|Recurrent Childhood Medulloblastoma | 2006-08 | PHASE2 |
| NCT04102098 | Hoffmann-La Roche | Carcinoma, Hepatocellular | 2019-12-31 | PHASE3 |
| NCT05480306 | Leap Therapeutics, Inc. | Colorectal Cancer|Colorectal Adenocarcinoma|Colo-rectal Cancer|Colorectal Cancer Metastatic | 2022-08-30 | PHASE2 |
| NCT01588184 | Hoffmann-La Roche | Neoplasms | 2012-07-13 | PHASE4 |
| NCT01582152 | M.D. Anderson Cancer Center|Cortice Biosciences, Inc. | Brain Neoplasms|Central Nervous System Neoplasms | 2012-07 | PHASE1|PHASE2 |
| NCT04776655 | Azienda USL Reggio Emilia - IRCCS|Istituto Di Ricerche Farmacologiche Mario Negri|Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale | Colorectal Cancer|Metastatic Colorectal Cancer|RAS Mutation | 2021-04-30 | PHASE3 |
| NCT00949247 | Case Comprehensive Cancer Center | Breast Cancer | 2009-12 | EARLY_PHASE1 |
| NCT00354549 | Swiss Cancer Institute | Lung Cancer | 2006-01 | PHASE2 |
| NCT06680258 | Tempest Therapeutics|Hoffmann-La Roche | Hepatocellular Carcinoma (HCC) | 2025-12 | PHASE3 |
| NCT05007132 | Dominik Paul Modest | Metastatic Colorectal Cancer | 2021-12-17 | PHASE2 |
| NCT04733963 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Colorectal Cancer | 2021-03-01 | PHASE2 |
| NCT00623233 | Eli Lilly and Company|Genentech, Inc. | Metastatic Breast Cancer|Locally Advanced Breast Cancer | 2008-03 | PHASE2 |
| NCT01858649 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain|Grand H?pital de Charleroi | Metastatic Colorectal Cancer | 2013-05 | PHASE2 |
| NCT01303926 | Gruppo Oncologico Italia Meridionale | Non-squamous Nonsmall Cell Neoplasm of Lung | 2010-01 | PHASE3 |
| NCT03607643 | Leaf Vertical Inc. | Cancer of Pancreas|Cancer of Liver|Cancer of Rectum|Cancer of Colon|Cancer, Gall Bladder|Myeloma Multiple|Glioblastoma Multiforme | 2019-01-15 | PHASE1|PHASE2 |
| NCT01125943 | Radboud University Medical Center|Dutch Cancer Society | Hypertension|Cancer|Endothelial Dysfunction | 2010-06 | NA |
| NCT04227028 | City of Hope Medical Center|National Cancer Institute (NCI) | Locally Advanced Lung Non-Small Cell Carcinoma|Metastatic Lung Non-Small Cell Carcinoma|Recurrent Lung Non-Small Cell Carcinoma|Stage III Lung Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8 | 2020-03-09 | PHASE1 |
| NCT01183663 | M.D. Anderson Cancer Center|Celgene | Advanced Cancers | 2010-08 | PHASE1 |
| NCT02248571 | iOMEDICO AG|Arbeitsgemeinschaft fur Internistische Onkologie|Novartis Pharmaceuticals | Breast Cancer Recurrent|HER2+Neu-negative Carcinoma of Breast|Hormone Receptor Positive Malignant Neoplasm of Breast | 2014-08 | PHASE4 |
| NCT00126633 | University of California, San Francisco|National Cancer Institute (NCI) | Pancreatic Cancer | 2004-04 | PHASE2 |
| NCT02985619 | University of Sao Paulo | Diabetic Macular Edema | 2016-07-21 | PHASE2|PHASE3 |
| NCT00387699 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) | Lung Cancer | 2006-10 | PHASE2 |
| NCT01996826 | Reza Dana, MD|United States Department of Defense|Bascom Palmer Eye Institute|New York Presbyterian Hospital | Corneal Neovascularization|Corneal Graft Failure | 2014-04 | PHASE1|PHASE2 |
| NCT01260506 | Vascular Biogenics Ltd. operating as VBL Therapeutics | Glioblastoma Multiforme | 2010-12 | PHASE1|PHASE2 |
| NCT06983704 | Benha University | Pediatric Glaucoma | 2024-02-09 | EARLY_PHASE1 |
| NCT01227707 | Hoffmann-La Roche | Colorectal Cancer | 2005-11 | PHASE2 |
| NCT04954014 | Maimónides Biomedical Research Institute of Córdoba | ARDS, Human|Coronavirus Infection | 2020-09-01 | PHASE2 |
| NCT05528952 | Centre Hospitalier Universitaire de Besancon|GERCOR - Multidisciplinary Oncology Cooperative Group|PRODIGE | Hepatocellular Carcinoma | 2022-09-27 | PHASE2 |
| NCT00543842 | M.D. Anderson Cancer Center|Genentech, Inc. | Rectal Cancer | 2007-12 | PHASE1 |
| NCT01763645 | Biocad | Non-small Cell Lung Cancer | 2012-10 | PHASE3 |
| NCT05325229 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Platinum-resistant Recurrent Ovarian Cancer | 2022-08-18 | PHASE2 |
| NCT04374305 | Scott R. Plotkin, MD, PhD|Takeda|The Children´s Tumor Foundation|National Comprehensive Cancer Network|Incyte Corporation | Neurofibromatosis Type 2|Vestibular Schwannoma|Non-vestibular Schwannoma|Meningioma|Ependymoma | 2020-06-20 | PHASE2 |
| NCT00049088 | National Cancer Institute (NCI) | Unspecified Adult Solid Tumor, Protocol Specific | 2002-08 | PHASE1 |
| NCT01490866 | SCRI Development Innovations, LLC|Pfizer | Colorectal Cancer | 2012-01 | PHASE2 |
| NCT06092242 | The Second Affiliated Hospital of Shandong First Medical University | Colorectal Cancer | 2023-10-15 | PHASE2 |
| NCT00070122 | National Cancer Institute (NCI) | Adenocarcinoma of the Colon|Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage III Colon Cancer|Stage III Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal Cancer | 2004-04 | PHASE3 |
| NCT06265688 | CytomX Therapeutics | Solid Tumor, Adult | 2024-04-02 | PHASE1 |
| NCT06796907 | GlaxoSmithKline | Tumours, Gynecological | 2025-03-04 | PHASE1|PHASE2 |
| NCT04224636 | Ludwig-Maximilians - University of Munich | Hepatocellular Carcinoma Non-resectable | 2020-06-10 | PHASE2 |
| NCT03793400 | Changhua Christian Hospital | Choroidal Neovascularization|Punctate Inner Choroidopathy | 2018-03-13 | |
| NCT02047214 | Cortice Biosciences, Inc. | Glioblastoma Multiforme | 2014-01 | PHASE2 |
| NCT00643565 | Hoffmann-La Roche | Sarcoma | 2008-07-29 | PHASE2 |
| NCT05314673 | University Hospital Fattouma Bourguiba | Pterygium | 2019-01-01 | PHASE4 |
| NCT02086656 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Colorectal Cancer Liver Metastases | 2013-06 | PHASE2 |
| NCT01468844 | National Eye Institute (NEI) | Retinal Vein Occlusion | 2011-12-21 | PHASE1|PHASE2 |
| NCT00948675 | Eli Lilly and Company | Advanced Non-Small Cell Lung Cancer | 2009-09-01 | PHASE3 |
| NCT03836157 | University of Oklahoma|ImmunoGen, Inc. | Endometrial Cancer|Endometrial Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Clear Cell Adenocarcinoma | 2019-05-31 | PHASE2 |
| NCT00130728 | Genentech, Inc. | Non-Small Cell Lung Cancer | 2005-06-08 | PHASE3 |
| NCT01025934 | University of Campania Luigi Vanvitelli|Napoli CTO Hospital | Proliferative Diabetic Retinopathy | | PHASE4 |
| NCT01767792 | University of Alabama at Birmingham|Genentech, Inc. | Neurofibromatosis Type 2|Progressive Vestibular Schwannomas | 2013-05-15 | PHASE2 |
| NCT03897192 | Changhua Christian Hospital | Punctate Inner Choroidopathy | 2018-10-01 | |
| NCT00745498 | Seoul National University Bundang Hospital | Proliferative Diabetic Retinopathy|Vitreous Hemorrhage | 2008-06 | NA |
| NCT02974621 | National Cancer Institute (NCI) | Recurrent Glioblastoma | 2017-12-07 | PHASE2 |
| NCT04524871 | Hoffmann-La Roche|Adagene Inc|Tempest Therapeutics|NiKang Therapeutics, Inc.|Immune-Onc Therapeutics | Advanced Liver Cancers | 2020-11-01 | PHASE1|PHASE2 |
| NCT05727163 | Sun Yat-sen University | Colorectal Cancer Metastatic | 2022-07-29 | PHASE2 |
| NCT05503667 | Shanghai Pulmonary Hospital, Shanghai, China | Lung Adenocarcinoma Stage III|Lung Adenocarcinoma Stage IV|EGFR Gene Mutation | 2022-02-01 | PHASE2 |
| NCT00749567 | Hellenic Oncology Research Group|University Hospital of Crete | Non-small-cell Lung Cancer | 2008-07 | PHASE2 |
| NCT01811498 | Northwell Health|Feinstein Institute for Medical Research | Glioblastoma Multiforme|Brain Tumor | 2013-02 | PHASE1|PHASE2 |
| NCT02393898 | Hoffmann-La Roche | Ovarian Cancer | 2015-04-23 | |
| NCT00804830 | Region Skane | Thyroid Neoplasms|Carcinoma|Thyroid Cancer|Metastatic Cancer | 2008-04 | PHASE2 |
| NCT06971744 | Medical University of South Carolina | Ovarian Cancer | 2025-12-18 | PHASE2 |
| NCT00290615 | Herbert Hurwitz|National Cancer Institute (NCI) | Colorectal Cancer | 2006-01 | PHASE2 |
| NCT03032484 | The University of Texas Health Science Center at San Antonio | Astrocytoma | 2017-05-18 | PHASE2 |
| NCT01763450 | Liaoning Cancer Hospital & Institute | Liver Metastases|Colorectal Cancer | 2012-09 | PHASE2 |
| NCT00708448 | University of Utah | Cancer|Non Small Cell Lung Cancer | 2008-03-28 | PHASE1 |
| NCT00586443 | Herbert Hurwitz, MD|Novartis|Genentech, Inc.|Amgen | Solid Tumors | 2007-11 | PHASE1 |
| NCT02305615 | Hoffmann-La Roche | Colorectal Cancer | 2015-01-13 | |
| NCT06294548 | University of Alabama at Birmingham | Hepatocellular Carcinoma | 2025-07-29 | PHASE1|PHASE2 |
| NCT06540326 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Colorectal Cancer Metastatic | 2024-11-12 | PHASE2 |
| NCT00107315 | Roswell Park Cancer Institute | Colorectal Cancer | 2004-07 | PHASE2 |
| NCT05093608 | H. Lee Moffitt Cancer Center and Research Institute|Karyopharm Therapeutics Inc | Hepatocellular Carcinoma | 2021-11-03 | PHASE1 |
| NCT01648348 | National Cancer Institute (NCI) | Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain Neoplasm | 2012-11 | PHASE1|PHASE2 |
| NCT01061515 | Washington University School of Medicine | Carcinoma | 2011-05-10 | PHASE1 |
| NCT00705315 | Hellenic Oncology Research Group | Breast Cancer | 2008-05 | PHASE1|PHASE2 |
| NCT00365417 | NSABP Foundation Inc|Genentech, Inc.|Hoffmann-La Roche|International Drug Development Institute | Breast Cancer | 2006-08 | PHASE2 |
| NCT00399750 | Sanofi | Colorectal Cancer | 2002-11 | PHASE2 |
| NCT00906685 | Anders Kvanta | Central Retinal Vein Occlusion | 2009-05 | PHASE3 |
| NCT06313268 | Laboratorios Liomont|Servicios Especializados en Ensayos Clínicos, S.C. | Metastatic Colorectal Cancer|Metastatic Cervical Cancer|Non Squamous Non Small Cell Lung Cancer | 2022-08-11 | |
| NCT01900717 | Centre Hospitalier Universitaire Dijon | Metastatic Colorectal Adenocarcinoma | 2011-07 | PHASE2 |
| NCT00407563 | Accelerated Community Oncology Research Network|Genentech, Inc.|Celgene Corporation | Epithelial Ovarian Cancer|Primary Peritoneal Carcinoma | 2007-01 | PHASE2 |
| NCT01516216 | Dana-Farber Cancer Institute | Metastatic Colorectal Cancer | 2012-04-13 | PHASE2 |
| NCT01020747 | Massachusetts General Hospital | Recurrent Respiratory Papillomatosis | 2009-11 | PHASE1 |
| NCT00804206 | Asociación para Evitar la Ceguera en México | Macular Edema | 2008-07 | PHASE4 |
| NCT01677884 | Gustave Roussy, Cancer Campus, Grand Paris | Colorectal Neoplasms | 2012-11 | PHASE2 |
| NCT05551208 | Chongqing University Cancer Hospital | Ovarian Cancer | 2022-08-15 | PHASE2 |
| NCT04952571 | Beijing Sanbo Brain Hospital | Recurrent Glioblastoma | 2021-06-27 | PHASE2 |
| NCT00805064 | Johann Wolfgang Goethe University Hospital | Retinal Vein Occlusion | 2006-01 | PHASE3 |
| NCT00436709 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Breast Cancer | 2006-07 | NA |
| NCT00636298 | Emory University|Genentech, Inc. | Esophageal Carcinoma | 2008-10 | PHASE2 |
| NCT03337698 | Hoffmann-La Roche | Carcinoma, Non-Small-Cell Lung | 2017-12-27 | PHASE1|PHASE2 |
| NCT02997228 | National Cancer Institute (NCI)|NRG Oncology | Metastatic Colorectal Adenocarcinoma|Stage IV Colorectal Cancer AJCC v7 | 2018-01-19 | PHASE3 |
| NCT04981509 | National Cancer Institute (NCI) | Hereditary Leiomyomatosis and Renal Cell Carcinoma|Papillary Renal Cell Carcinoma|Renal Cell Carcinoma|Sporadic Papillary Renal Cell Carcinoma|Stage III Renal Cell Cancer AJCC v8|Stage IV Renal Cell Cancer AJCC v8 | 2022-06-10 | PHASE2 |
| NCT00819754 | Ottawa Hospital Research Institute|Hoffmann-La Roche|Pfizer|Sanofi|Ottawa Regional Cancer Foundation | Metastatic Colorectal Cancer | 2003-11 | PHASE1|PHASE2 |
| NCT00193154 | SCRI Development Innovations, LLC|AstraZeneca|Genentech, Inc. | Kidney Cancer | 2003-02 | PHASE2 |
| NCT02511405 | Vascular Biogenics Ltd. operating as VBL Therapeutics | Glioblastoma | 2015-08 | PHASE3 |
| NCT04541173 | Aiwu Ruth He, MD|Georgetown University|Genentech, Inc. | Hepatocellular Carcinoma | 2020-11-30 | PHASE2 |
| NCT00442637 | Dutch Colorectal Cancer Group|Koningin Wilhelmina Fonds|Sanofi|Hoffmann-La Roche | Colorectal Cancer Metastatic | 2007-01 | PHASE3 |
| NCT00369070 | Amgen | Advanced Non-squamous NSCLC | 2007-01-31 | PHASE2 |
| NCT06951503 | Akeso | Colorectal Adenocarcinoma | 2025-05-27 | PHASE3 |
| NCT01834014 | EPS Corporation | Liver Metastasis|Colorectal Cancer | 2013-05 | NA |
| NCT00565656 | Centre Hospitalier Universitaire de Nice | Myelodysplastic Syndromes | 2007-07 | PHASE2 |
| NCT04679064 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS|GlaxoSmithKline | Ovarian Cancer | 2020-12-01 | PHASE3 |
| NCT02336165 | Ludwig Institute for Cancer Research|MedImmune LLC|Cancer Research Institute, New York City|Cure Brain Cancer Foundation, Australia | Glioblastoma | 2015-02-26 | PHASE2 |
| NCT02497157 | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan|Hiroshima Prefectural Hospital|National Hospital Organization Shikoku Cancer Center | Metastatic Colorectal Cancer | 2015-05-21 | PHASE2 |
| NCT03942328 | Mayo Clinic|National Cancer Institute (NCI) | Stage III Hepatocellular Carcinoma AJCC v8|Stage III Intrahepatic Cholangiocarcinoma AJCC v8|Stage IV Hepatocellular Carcinoma AJCC v8|Stage IV Intrahepatic Cholangiocarcinoma AJCC v8|Unresectable Hepatocellular Carcinoma|Unresectable Intrahepatic Cholangiocarcinoma | 2019-09-19 | PHASE1|PHASE2 |
| NCT04425681 | Second Affiliated Hospital of Nanchang University|Nanchang University | Leptomeningeal Metastasis|Non-small Cell Lung Cancer|EGFR Activating Mutation | 2017-10-01 | PHASE2 |
| NCT00553800 | Fox Chase Cancer Center|Genentech, Inc.|OSI Pharmaceuticals | Carcinoma, Non-Small-Cell Lung | 2007-07-05 | PHASE2 |
| NCT00868192 | Washington University School of Medicine|Columbia University | Ovarian Carcinoma|Primary Peritoneal Carcinoma | 2008-05 | PHASE2 |
| NCT01894061 | Case Comprehensive Cancer Center|NovoCure Ltd. | Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor | 2013-09-18 | PHASE2 |
| NCT01871766 | St. Jude Children´s Research Hospital | Rhabdomyosarcoma | 2013-12-04 | PHASE2 |
| NCT01418222 | Genentech, Inc.|SCRI Development Innovations, LLC | Colorectal Cancer | 2011-09-14 | PHASE2 |